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Abstract 
During my Ph.D. training, my research has been focused on two distinct topics: 
investigating the immunologic fuction of Virtual Memory CD8+ T cells; and elucidating 
the role of KLF2 in effector CD4+ T cell lineage commitment. 
In the first part (Chaper 2), we investigate the immunologic properties of foreign-
antigen specific memory-phenotype T cells, termed Virtual Memory (VM).  Our data 
indicates that VM cells differ functionally from “true memory” cells, yet VM cells 
efficiently control a bacterial (Listeria monocytogenes) infection. These data support the 
novel concept that naturally occurring VM cells contribute to “pre-immune” resistance to 
infection.  
In the second part (Chapter 3), we find that expression of the transcription factor 
Kruppel-like factor 2 (KLF2) expression varies in distinct Th subsets, and 
downregulation of KLF2 and the trafficking molecule S1PR1 (the well-defined target of 
KLF2) is required for Tfh differentiation. In addition to promoting S1PR1 expression, we 
also find that KLF2 induces expression of Blimp-1, which is known to oppose Tfh 
differentiation. Furthermore, KLF2 also promotes expression of T-bet and Gata3, and 
enhances Th1 differentiation. These data reveal that KLF2 plays an important role in 
dictating the lineage differentiation of CD4+ T cells. 
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Chapter 1 
Introduction 
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In the immune system, multiple cellular components are closely connected with 
their environment to trigger appropriate immune responses against pathogens.  At the 
same time, these cell populations are tightly regulated to maintain homeostasis of the 
system and prevent immunopathology. To achieve the goals and ensure the survival of 
the organism, the mammalian system has developed two complementary, but distinct 
arms: the innate and adaptive immune systems1.   
 The innate immune system is the frontline defense of host that recognizes 
evolutionary conserved pathogen- and danger- associated molecular patterns (PAMPs 
and DAMPs) by using several types of pattern recognition receptors1-5. Therefore, 
although the innate immune system is non-specific and can’t distinguish individual 
pathogens, the innate immune response is rapid and able to offer some degree of 
pathogen elimination in the acute phase of the infection1,4,5. However, while innate 
immunity remains essential for the rapid response to a pathogen, some pathogens cannot 
be controlled by the non-specific innate immune response alone. When the innate 
immune system fails to control, the adaptive immune response is initiated by the antigen 
presenting innate immune cells (e.g. dendritic cells) which induce antigen-specific 
immune responses.  In addition to assisting in elimination of a primary infection, 
activation of adaptive immune cells results in the generation of “immunologic 
memory”1,6. Therefore, although the adaptive immune response takes a longer period of 
time to develop than the non-specific innate immune response, the adaptive immune 
response is antigen-specific and provides long-lasting robust immunity against 
subsequent infection of same pathogen1,6. Hence, understanding how the adaptive 
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immune system functions is significant to the development of therapeutics and well as 
vaccines.  
Therefore, I have studied the effector mechanisms of the adaptive immune 
response. Especially, among the adaptive immune system, my thesis researches has 
focused on investigating the peripheral effector function of T lymphocytes against 
cognate pathogens, as well as the molecular mechanism of effector lineage 
differentiation. Therefore, in this chapter, I will introduce background information 
relevant to these areas of my thesis research. 
 
 
Adaptive immune response 
As described above, one of the biggest differences between the innate and 
adaptive immune response is antigen-specificity. Innate immune responses initially 
protect the host against pathogen, but those only work to control pathogens that include 
certain molecular patterns or that induce host danger signals (e.g. interferon, apoptosis 
etc.). To efficiently fight the broad range of pathogens, B cells and T cells, which are the 
two main effector populations in the adaptive immune system, have evolved to recognize 
a great variety of different non-self antigens from environment. For B cells, membrane-
bound immunoglobulin (Ig) on the cell surface serves as the antigen recognition receptor, 
and is known as the B cell receptor (BCR), which is also secreted as antibody by 
terminally differentiated plasma cells upon encountering the specific antigen. Similar to 
B cells, T cells also recognize their specific antigen with membrane-bound T cell 
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receptors (TCRs). However, unlike BCRs that recognize and bind the specific antigen by 
itself, TCRs instead recognize peptide fragments of protein antigens that are presented by 
the major histocompatibility complex (MHC) on host cell surface1. Also, T cells do not 
secrete their antigen receptors, and their function depends on physical localization at sites 
of antigen presentation or infection.  With the specific antigen receptors, the adaptive 
immune cells can specifically recognize only one cognate antigen and leads to cellular 
activation and clonal expansion that provide a robust specific response against the 
invading pathogen1,6. 
 
General overview of T cell immune response 
 In the periphery, depending on the antigen experience and activation status, T 
cells can largely be sub-populated into three: naïve, effector and memory T cells1. After 
differentiation in the thymus, T cells express a trafficking receptor, sphingosine 1-
phosphate receptor 1 (S1PR1), and migrate to the bloodstream by following a 
concentration gradient of its ligand sphingosine 1-phosphate (S1P)7,8. On reaching the 
periphery, the T cells continuously circulate throughout the body between the lymphatic 
and cardiovascular system by using several other trafficking molecules (e.g. CD62L, 
CCR7 etc.) on their surface, and patrol secondary lymphoid organs (lymph nodes and the 
spleen) where they search for APC presenting their specific cognate antigen7,8. Mature 
circulating T cells that haven’t encountered their specific antigen are defined as naïve T 
cells8.  
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Once naïve T cells encounter their cognate antigen, they proliferate and 
differentiate into effector T cells, and acquire new activities that contribute to removal of 
the antigen. Besides the cognate antigen recognition by specific TCR (sigal 1), effector T 
cell differentiation is also critically influenced by the type, timing, strength, and duration 
of costimulatory (signal 2) and cytokine (signal 3) stimulation9. Signal 2 is provided by 
costimulatory molecules (e.g. CD80/CD86) expressed on activated antigen presenting 
cells (APCs)10. When professional APCs (such as DCs, macrophages, and B cells) are 
primed by PAMPs and DAMPs, they upreguate co-stimulatory molecules which are 
recognized by CD28 on the T cell. Stimulation through CD28 in addition to TCR signal 
is required for effector T cell differentiation, and TCR signaling without CD28:CD80/86 
interaction results in inducing T cell anergy10. The signal 3 is various cytokines. TCR and 
costimulatory signals initiate proliferation of naïve cells, but in the absence of a specific 
cytokine signal the cells fail to develop optimal effector functions, survive poorly, and do 
not form a responsive memory population9-11. When all three signals are present, a T cell 
becomes fully activated and is able to differentiate into an effector T cell that is capable 
of contributing to the elimination of an invading pathogen.  
At last, following the elimination of the infecting pathogen, effector T cells 
undergo a contraction phase wherein the majority of pathogen-specific effector T cells 
die by apoptosis, but typically a small percentage (~5–10%) survive to further mature 
into memory T cells. As described above, this memory T cell population is long lived and 
gives an enhanced response to cognate antigen, which yields protection from subsequent 
challenge by the same pathogen11-13. 
   6 
 
CD8 and CD4 T cells 
Phenotypically T cells can be categorized into two main subsets, CD4 expressing 
T cells and CD8 expressing T cells which recognize different types of MHCs14. On 
antigen recognition, naïve T cells differentiate into several functional classes of effector 
T cells that are specialized for different activities. CD8 T cells recognize pathogen 
peptides presented by MHC class I molecules, and naïve CD8 T cells differentiate into 
effector T cells that kill infected cells (through granzymes and perforin) and secrete 
cytokines such as interferon-γ (IFNγ) and tumour necrosis factor (TNF)11. CD4 T cells 
have a more flexible repertoire of effector activities. After recognition of pathogen 
peptides presented by MHC class II molecules, naïve CD4 T cells differentiate down 
distinct pathways that generate effector subsets with different immunological functions. 
The main CD4 effector subsets currently distinguished are Th1, Th2, Th17 and follicular 
helper T (Tfh) cells, which promote immune responses, and several regulatory T (Treg) 
subsets that have inhibitory activity and limits the extent of immune activation15,16. 
Therefore, CD8+ T cells are known as “cytolytic” upon activation and are equipped to 
directly kill infected cells where as CD4+ “helper” T cells produce cytokines that help 
activate other cell types that eventually control an infection11,15,16. The detailed immune 
function of each effector T cell lineages will be discussed in later section of this 
introduction. 
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Effector and memory CD8 T cell 
 Effector CD8 T cells perform cytotoxic activities and are essential in host defense 
against cytosolic, most commonly viruses and intracellular bacteria. These cytotoxic T 
cells can kill cells harboring such pathogens by recognizing foreign peptides that are 
transported to the cell surface bound to MHC class I molecules1,11.  
Functionally, effector CD8 T cells can uniformly be categorized as cytotoxic T 
cells. But, conceptually, effector CD8 T cells have been further divided into at least two 
subsets based on their memory potential, memory precursor effector cells (MPECs) that 
can become long-lived memory CD8 T cells and short-lived effector cells (SLECs) that 
do not17. Previous studies using acute infection model (e.g. Lymphocytic choriomeningitis 
virus (LCMV), Listeria Monocytogenes (LM)) have found that some effector cell subsets 
persist long-term and populate the memory cell pool, and in many cases these cells can be 
identified based on increased expression of interleukin-7Rα (CD127), CD27, and B cell 
lymphoma 2 (Bcl2) and decreased expression of effector molecule, KLRG117. For the 
cell fate decision between MPEC and SLEC, the amount and duration of antigenic (signal 
1) and inflammatory cytokine (signal 3) stimuli have been suggested as the critical 
players though regulating expression of effector transcription factors (e.g. T-bet, Eomes, 
Blimp-1)17. These results indicate that the innate immune system sets the relative 
amounts of a lineage-determining transcription factor in activated CD8 T cells during 
primary immune response, as well as regulates memory cell potential of the effector CD8 
T cells. 
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It has been classically accepted that there are two main memory T cell 
populations: central memory T cells (Tcm) and effector memory T cells (Tem), based on 
their trafficking molecule expression18,19. Tcm express high levels of the lymphoid organ 
homing molecules, CCR7 and CD62L, and Tem express low levels of CCR7 and CD62L. 
The differential expression of these trafficking molecules on memory T cells suggests 
localization and functional differences between these two memory subsets18,19.  With the 
CCR7 and CD62L expression, Tcm have the potential to recirculate through secondary 
lymphoid organs due to the expression of CCR7 and CD62L and preferentially migrate 
into the inflamed lymph nodes to proliferate rapidly, but take longer to differentiate into 
effector cells18,19. On the other hand, CD62Llo/ CCR7lo Tem can more preferentially 
access peripheral non-lymphoid tissues (NLT) where the inflammation occurs, and 
rapidly induce effector function to eliminate the pathogen18,19. More recently, another 
subset of memory CD8 T cells, called resident memory T cells (Trm), has been 
identified18,20. Although this population shares the NLT migratory capacity of Tem, Trm 
don’t recirculate through the body (like “classic” Tem) but are instead maintained as a 
long-term resident population in diverse NLTs20. More importantly, recent studies clearly 
have shown that Trm cells provide better protection against local secondary infections 
than circulating memory cells21. Thus, Trm cells are now recognized as critical sentinels 
in peripheral sites. 
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Effector CD4 T cell lineages  
In contrast to CD8 T cells that mainly differentiate into cytotoxic T cells, CD4 T 
cells can differentiate into a variety of effector subsets, including Th1, Th2, Th17 cells, 
follicular helper T (Tfh) cells, and induced regulatory T (iTreg) cells that have unique 
functional properties1,15,16. Functionally, Th1 cells are characterized by their production 
of IFN-γ and are involved in cellular immunity against intracellular microorganisms. Th2 
cells produce IL-4, IL-5, and IL-13 and are required for humoral immunity to control 
extracellular pathogens. Th17 cells produce IL-17A, IL-17F, and IL-22 and play 
important roles in clearance of extracellular bacteria and fungi, especially at mucosal 
surfaces. Tfh cells are a subset of helper T cells that regulate the maturation of B cells 
and initiate the germinal center responses to generate high-affinity neutralizing 
antibodies1,15,16. 
The basis for CD4 T cell differentiation decisions are still being defined. But the 
cytokines in the microenvironment (signal 3) and lineage specific transcription factors 
induced by the cytokine signaling have been shown as critical players in the lineage 
commitment1,15,16. For Th1 lineage, IL-12 produced by innate immune cells and IFN-γ 
produced by both NK cells and T cells polarize cells toward the Th1 cell differentiation 
program through action of STAT4, STAT1, and T box transcription factor T-bet. Th2 cell 
differentiation requires the action of GATA3 downstream of IL-4 and Stat6. Th17 cell 
differentiation requires a transcription factor, RORγt that is induced by TGF-β in 
combination with the pro-inflammatory cytokines IL-6, IL-21, and IL-23, all of which 
induce STAT3 phosphorylation. The cytokine requirement for Tfh cell differentiation is 
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less clear than other subsets, but a recent study suggested that TGF-β signaling through 
STAT3, STAT4 is essential for human Tfh differentiation22, and the differentiation may 
be dependent on the transcription factor Bcl-61,15,16. 
 
Virtual memory CD8 T cells 
It has long been assumed that memory cells are only formed following “naïve” T 
cell encounter with specific foreign antigen presented on MHC molecule9,17,23-25. 
However, a series of previous studies showed that various homeostatic cues also can 
induce “naïve” T cells to acquire “memory-like” properties, without foreign antigen 
induced priming12,26-31.  
During studies on T cell homeostasis, it was found that naive CD8 T cells 
undergo proliferation in lymphopenic environments (termed homeostatic proliferation or 
lymphopenia-induced proliferation) by both engagement of the TCR with self-
peptide/MHC ligands and signal of various cytokines (including IL-2, IL-4, IL-7 and IL-
15)24,32,33. And in the process of lymphopenia-induced proliferation, the naïve CD8 T 
cells obtain memory-like phenotype and function24,33. They elevate expression of several 
functional effector molecules that are highly expressed on antigen-primed conventional 
memory CD8 T cells (such as CD44, CD122 (IL-2 receptor β) and CXCR3), and provide 
superior protection against infection24,33. Lymphopenia occurs not only in artificial 
situations (e.g. in immune-deficient or irradiated animals): physiological lymphopenia 
also occurs during the neonatal period in mice, and induces production of memory-
phenotype T cells24,26. More importantly, our previous study, using peptide/MHC 
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tetramers in combination with magnetic enrichment protocol, showed that unimmunized 
mice contained a population of foreign antigen specific memory-like CD8 T cells, termed 
Virtual Memory (VM) CD8 T cells26,27. These findings do clearly show that antigen non-
experienced phenotypic “memory” CD8 T cells arise through homeostatic mechanisms 
during normal immune system development, and suggest this population of cells may be 
active participants in “primary” immune responses against “foreign” pathogen. However, 
the antigen specific function of VM CD8 T cells was poorly characterized during actual 
cognate pathogen infection, and hence their potential contribution to immune responses 
was unclear.   
 
Kruppel-like Factor 2 (KLF2) function in T cell 
 KLF2 is a zinc-finger transcription factor that binds to CACCC domain or other 
GC-rich DNA sequences allowing them to exert their transcriptional regulation. Since 
1995 when KLF2 was originally identified, KLF2 has been shown to have many roles in 
multiple cells from vascular development to immune cell function8.  
In T cell immunology, my lab and other groups have reported that KLF2 has 
multiple critical roles in peripheral T cell trafficking though directly regulating key 
trafficking molecules, such as L-selectin (CD62L) and S1PR17,8,20. KLF2 expression is 
increased in the late stages of thymocyte development and maintained during naïve T cell 
stage that subsequently promotes CD62L and S1PR1 expression in mature single positive 
(SP) thymocyte and naïve T cells7,8. As briefly described above, S1PR1 is essential for 
thymic egress of mature SP T cells, as well as secondary lymphoid organ exit of naïve T 
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cells in periphery34,35. Thus, with increased expression of KLF2 and S1PR1, mature SP T 
cells can migrate toward blood stream. Indeed, the accumulation of KLF2 deficient 
mature T cells in the thymus is prevented by overexpression of S1PR1, suggesting that 
this factor is the key target of KLF2 for thymic emigration36,37. In addition, KLF2 also 
directly promotes expression of CD62L, which is required for access of naive T cells to 
lymph nodes, indicating that this KLF coordinates opposite aspects (both exit and entry) 
of lymphocyte trafficking. For this reason, KLF2 can be considered a regulator of naïve T 
cell circulation, allowing naïve T cells to circulate throughout lymph nodes and back into 
the blood. 
During immune response, KLF2 expression in T cells is dynamic and determined 
by both the strength and duration of TCR and cytokine signaling8. Previous studies have 
shown that KLF2 is highly expressed in naive T cells but rapidly down-regulated at the 
protein and mRNA level in response to triggering of the T cell antigen and cytokine 
receptor, which provides a mechanism for the initial retention of activated T cells in 
lymphoid tissues8. But, the loss of KLF2 in early-activated T cell is recovered in fully 
differentiated effector T cells that allows them to re-enter the blood stream and migrate to 
the infected tissues8,20. At the memory stage, KLF2 expression in different memory T cell 
subsets varies, and the differential expression of KLF2 determines recirculation potential 
of the memory T cell subsets. In recent data, we showed that KLF2 is continuously 
down-regulated in “Resident Memory” CD8 T cells (Trm), a population that is prominent 
in non-lymphoid tissues and does not appear to exchange with other sites through 
recirculation via the blood and lymph.  On the other hand, memory CD8 T cells 
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circulating in the blood or found in lymphoid sites such as lymph node show high KLF2 
expression20. Moreover, the level of KLF2 impact transcriptional program (e.g. T-Bet, 
Blimp-1) of effector T cells38,39, and the down-regulation of KLF2 during effector phase 
of immune response is required for Trm generation20. Collectively, these previous 
findings have suggested that KLF2 may also have critical immunologic role in T cell 
differentiation besides trafficking. However, the regulation and function of KLF2 in 
peripheral effector and memory T cells are still less clear and needed to be further 
explored.  
 
Statement of thesis 
This thesis includes two conceptually different studies. The one is about the 
immunologic function of Virtual Memory CD8+ T cells (chapter 2), and the other is 
about the role of KLF2 in effector CD4+ T cell lineage commitment (chapter 3). 
In chapter 2, specifically, my study is focused on elucidating the foreign antigen 
specific response of naturally occurring memory-phenotype CD8 T cells. Our previous 
studies indicated that foreign antigen specific memory-like CD8 T cell, termed Virtual 
Memory (VM), populations arise through homeostatic mechanisms during normal 
immune system development26,27. Also, some preliminary data of ours indicated that this 
VM population also displays some functional properties of antigen-primed “True” 
memory (TM) cells. Therefore, we hypothesized that the VM CD8 T cells might provide 
important pre-immune protection against cognate pathogens. To test this hypothesis, I 
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focused on characterizing the foreign antigen specific response of VM CD8 T cells and 
comparing them to naïve and TM populations. 
In the second project (chapter 3), I studied the transcriptional regulation of KLF2 
and its role in effector CD4 T cell determination. My initial collaborative work focused 
on CD8+T cells showed that KLF2 and its transcriptional target S1PR1 have a critical 
role in determining memory CD8 T cell lineage between recirculating (Tcm) or tissue-
resident memory (Trm) populations (not included in this dissertation)20. Also, recent 
studies from others using CD8 T cells showed KLF2 may directly affect to several 
effector transcription factors (T-Bet, Blimp-1) which also have a critical role in CD4 T 
cell effector differentiation38,39. Based on these previous studies, we hypothesized that 
KLF2 might also have a critical regulatory role in effector CD4 T cell lineage 
commitment during antigen-specific immune response.  
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Chapter 2 
 Immunologic function of the foreign antigen specific homeostatic memory  
(Virtual memory (VM)) CD8+ T cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reprinted from the Proceedings of the National Academy of Sciences. June-Yong Lee, 
Sara E. Hamilton, Adovi D. Akue, Kristin A. Hogquist and Stephen C. Jameson. “Virtual 
memory CD8 T cells display unique functional properties.” Proc Natl Acad Sci U S A. 
2013 Aug 13;110(33):13498-503. Copyright 2013. 
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Previous studies revealed the existence of foreign antigen specific memory 
phenotype CD8 T cells in unimmunized mice.  Considerable evidence suggests this 
population, termed Virtual Memory (VM) CD8 T cells, arise via physiological 
homeostatic mechanisms.  However, the antigen specific function of VM cells is poorly 
characterized, and hence their potential contribution to immune responses against 
pathogens is unclear. Here we show that naturally occurring, polyclonal VM cells have 
unique functional properties, distinct from either naïve or antigen-primed memory CD8 T 
cells.  In striking contrast to conventional memory cells, VM cells showed poor TCR-
induced IFN-γ synthesis and preferentially differentiated into central memory phenotype 
cells after priming.  Importantly, VM cells showed efficient control of Listeria 
monocytogenes (LM) infection, indicating memory-like capacity to eliminate certain 
pathogens.  These data suggest naturally arising VM cells display novel functional traits, 
allowing them to form a bridge between the innate and adaptive phase of a response to 
pathogens. 
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Introduction 
  While the function of memory T cells generated by exposure to foreign antigens 
is well studied, far less is understood about the properties of memory-like T cells, which 
are produced in response to homeostatic processes.  Numerous studies have shown that 
lymphopenic conditions can drive naïve CD4 and CD8 T cells to proliferate and acquire 
phenotypic traits of memory cells12,24,28,29,31.  Furthermore, studies on lymphopenia-
induced “homeostatic memory” CD8 T cells suggest they also resemble foreign antigen 
primed “true” memory (TM) cells in their functional properties – including the ability to 
rapidly produce IFN-γ, and control of bacterial and viral infections32,33,40.  Yet, 
differences in phenotype and function have been noted in comparison between the 
homeostatic memory and TM CD8 T cells, including altered kinetics of responses to 
pathogen and distinct expression of integrins27,41.  Such findings indicate that homeostatic 
processes do not completely mimic the TM pool, and suggests there may be distinct 
functional capacities of these populations.   
In addition, our studies and others indicate that normal animals possess a 
population of unprimed memory-like CD8 T cells, which we termed “virtual memory 
(VM)” cells (to distinguish them from the induced homeostatic memory pool discussed 
above)27.  These cells appear soon after birth in normal mice26, and have been found to 
comprise 5-20% of CD8 T cells specific for diverse foreign antigens26,27,42-45.  The 
finding that VM cells arise at similar frequencies in germ-free mice supports the model 
that such cells are produced by homeostatic mechanisms, rather than stimulation by 
environmental or commensal microbes27. The fact that VM CD8 T cell appear in neonatal 
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mice might indicate a role in protective immunity at this vulnerable stage26, but VM cells 
also increase in frequency during aging, and studies on HSV responsive cells revealed 
that T cells with high avidity for the viral antigen were selectively maintained in the VM 
pool44.   Furthermore, responses by high avidity cells correlated with enhanced pathogen 
control in older animals, suggesting a mechanism through which VM cells may 
compensate for functional defects in the aging immune system44.    
However, the functional properties of naturally arising VM cells have not been 
clearly defined.  In earlier studies, we were surprised to observe that in vivo TCR 
stimulation did not result in production of IFN-γ by antigen specific VM cells27 – a result 
indicating that VM CD8 T cells differ from either conventional or lymphopenia-driven 
homeostatic memory cells (both of which are potent producers of this cytokine)32,40.   
Such findings raised the possibility that, while displaying memory phenotype, the VM 
pool retains naïve functional properties, or may even be functionally compromised – and 
hence contribute little to an immune response.  Furthermore, several studies suggest that 
memory-phenotype CD8 T cells (from unimmunized mice) exert a regulatory role, acting 
to inhibit CD4 and CD8 T cell responses46-50.  Whether the antigen specific VM 
population serves to restrain, rather than enhance, immune reactivity has not been tested, 
and is especially relevant for their potential role in protective immunity against 
pathogens.   
Here we study the functional traits of spontaneously arising VM CD8 T cells, and 
find that this population differs from both naïve and TM CD8 T cells.  In vitro studies 
revealed that VM CD8 T cells manifest certain functions of TM CD8 T cells (e.g. 
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increased T-box transcription factors expression and advanced G1 cell cycle status), but 
also naïve-like properties, such as poor IFN-γ production after antigen stimulation.  
Moreover, VM CD8 T cells display qualitative and quantitative differences with naïve 
and TM counterparts during antigen specific immune response in vivo yet, importantly, 
VM provide potent antigen-specific protective immunity against LM infection, similar to 
antigen-primed memory CD8 T cells.  Together our data suggest that, despite their 
distinct characteristics in comparison with conventional memory and naïve CD8 T cells, 
VM cells display enhanced functional properties that allow them to mount a more 
effective immune response during primary pathogen encounter.  
 
  
 
 
 
 
 
 
 
 
   20 
Results  
Although virtual memory (VM) cells constitute 5-20% of the foreign antigen 
specific CD8 T cell population in unprimed mice26,27,42-44, the very low frequency of 
precursors for a given MHC/peptide ligand makes functional assessment of VM CD8 T 
cells challenging.  To solve this problem, we utilized mice expressing the rearranged 
TCR β-chain of the OVA-specific OT-I TCR (henceforth called “Vβ5 Tg”).  Pairing of 
this TCR chain with endogenously rearranged TCR α-chains generates a diverse, 
polyclonal repertoire, yet leads to an elevated precursor frequency (~1-2%) of CD8 T 
cells specific for Ova/Kb in unimmunized Vβ5 Tg mice51,52 (Fig. 1A).  Importantly, both 
total CD8 T cell numbers and the frequency of memory-phenotype (CD44hi, CD122hi, 
CXCR3hi, Ly6Chi) CD8 T cells are similar in Vβ5 Tg and normal B6 mice (Fig. 1B and 
D).  Likewise, analysis of foreign antigen specific CD8 T cells (identified using 
peptide/MHC tetramers) in unprimed mice showed that the frequency and phenotype of 
Ova/Kb specific VM cells in Vβ5 Tg mice was similar to polyclonal VM cells in normal 
B6 mice (Fig. 1D)27.  The expression of these markers on Ova/Kb tetramer-binding VM 
cells mirrored that of Ova/Kb specific TM cells (generated by LM-OVA priming of 
adoptively transferred Vβ5 Tg CD8 T cells) (Fig. 1D).  However, while the TM 
population included both CD62L+ and CD62L- populations (i.e. Central and Effector 
memory phenotype cells, respectively), the antigen specific VM population was 
uniformly CD62L+ (Fig 1D).  Furthermore, Vβ5 VM cells displayed low levels of α4 
integrin (CD49d) when compared to antigen primed TM cells (Fig. 1C and D), in keeping 
with previous studies on phenotypic differences between polyclonal VM and TM 
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populations27,45.  Hence, the phenotype of naïve and VM CD8 T cells within the Ova/Kb 
specific population of Vβ5 mice resembled that of normal mice, yet the elevated 
frequency of OVA-specific cells in Vβ5 mice provided an opportunity to compare the 
antigen-specific responses by naïve, VM and TM subsets.   
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Figure 2-1.  Analysis of CD8 T cell subsets derived from Vβ5 tg mice.  (A) 
Representative data on the frequency and CD44 expression phenotype of OVA/Kb-
specific CD8 T cells in unprimed Vβ5 tg mice.  (B) Number of CD8 T cells in unprimed 
WT B6 mice and Vβ5 tg mice. Statistical significance between the number of CD8 T 
cells from WT B6 and Vβ5 mice is not significant (“n.s.”, P >0.05, Student t test). (C) 
CD49d expression of Ova/Kb tetramer+ naïve, VM and TM Vβ5 CD8 T cells. (D) 
Comparison of cell surface marker expression (CD122, Ly-6C, CXCR3, CD49d and 
CD62L) between indicated populations of normal and Vβ5 CD8 T cells.  Ova/Kb specific 
unprimed and TM Vβ5 CD8 T cells were detected by an appropriate combination of 
congenic markers and Ova/Kb tetramer staining. Tetramer+ve CD8 T cells from wild type 
B6 mouse were stained with a cocktail of tetramers (Ova/Kb, B8R/Kb, HSVgB/Kb) and 
enriched by tetramer pull-down assay. All the data is representative of more than 3 
experiments.  
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VM CD8 T cells share some in vitro functional traits with “true” memory CD8 T 
cells. 
Previous studies suggest that antigen-driven TM CD8 T cells display changes in 
gene expression, cytokine production and cell cycle regulation, all of which are thought 
to enhance the capacity of these cells to rapidly enter an immune response23,53.  Hence we 
investigated whether VM share these features with TM.   
The T-box transcription factors, T-bet and Eomes, serve as critical regulators of 
effector functions and differentiation of memory CD8 T cells, and both factors are 
upregulated in TM cells54-56.  Expression of both T-bet and Eomes were significantly 
increased on both VM and TM populations, compared to naïve Ova/Kb tetramer+ Vβ5 Tg 
CD8 T cells, although we observed reciprocal differences between the memory 
populations in the extent of T-bet and Eomes upregulation (Fig. 2A).  RT-PCR analysis 
confirmed these expression patterns at the transcriptional level (Fig. 2B).  Hence, these 
data indicate that VM cells express not only memory phenotypic markers (Fig. 1D), but 
also key transcription factors characteristic of TM CD8 T cells.   
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Figure 2-2.  Expression of T box transcription factors on naïve, VM and TM CD8 T 
cells. (A) Expression of T-bet and Eomes on Ova/Kb specific VM, naïve and TM Vβ5 
CD8 T cells were determined by FACS. Data are representative of at least 3 independent 
experiments. (B) qRT-PCR analysis of indicated genes on sort purified CD44high and 
CD44low Vβ5 CD8 T cells from unprimed mice, in comparison with TM Vβ5 CD8 T 
cells (from immunized mice).  Relative gene expression levels were normalized by 
GAPDH, and the levels in CD44low Vβ5 CD8 T cells were chosen as the baseline for 
comparison.  Data are compiled from 3 independent experiments using independently 
generated cDNAs (n=3) and graphs show mean +/- SD. 
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Figure 2-3.  Comparison of cell cycle status between naïve, VM and TM CD8 T cells. 
Cell-cycle analysis of indicated Vβ5 CD8 T cell populations.  (A) Represented FACS 
plot showing amount of intracellular DNA and RNA that indicate cell cycle status of 
cells.  Numbers in boxed areas indicate percentage of cells in each.  (B) Analysis of cell 
cycle status on indicated populations.  Data are compiled from at least 3 experiments and 
bars show the mean +/- SD.  Statistical significance is indicated (***, p<0.001, “n.s.” 
(“not significant”) is used to denote P-values >0.05, Student t test).
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Previous studies showed that most TM are maintained in G1 phase of the cell 
cycle, which has been proposed to allow them to progress to proliferation more quickly 
than naïve CD8 T cells57,58.  Hence we analyzed intracellular RNA and DNA levels58 to 
investigate the cell cycle status of VM, TM and naïve CD8 T cell populations (Fig. 3A).  
As expected, very few (<1%) cells of any type showed signs of active progression 
through cell cycle (i.e. S/G2/M phases) at steady state (Fig. 3A), but the VM and TM 
populations were significantly enriched in cells at G1 phase, compared to the naïve pool 
(Fig. 3A, B).  Furthermore, gene expression of cell cycle regulators associated with G1 
phase (CDK6 and CyclinD3)57,59 showed significantly elevated expression in both 
memory populations (Fig. 4). 
 
Figure 2-4.  G1 cell cycle regulatory gene expression in naïve, VM and TM CD8 T 
cells. qRT-PCR analysis of cell cycle regulatory genes on sort purified CD44high and 
CD44low Vβ5 CD8 T cells from unprimed mice, in comparison with TM Vβ5 CD8 T 
cells (from immunized mice).  Relative gene expression levels were normalized by 
GAPDH, and the levels in CD44low Vβ5 CD8 T cells were chosen as the baseline for 
comparison.  Data are compiled from 3 independent experiments using independently 
generated cDNAs (n=3). Graphs show mean +/- SD and statistical significance is 
indicated (***, p<0.001; *, p<0.05, while “n.s.” (“not significant”) is used to denote P-
values >0.05, Student t test) 
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Memory CD8 T cells are characterized by basal proliferation, which maintains 
their numbers long-term60,61. Our data showed that both TM and VM populations have 
advanced cell cycle status in G1 phase (Fig. 3, 4), suggesting VM may undergo the 
memory like basal proliferation. However, it is not clear whether a similar process occurs 
for the VM population. To explore this issue, we measured BrdU incorporation during a 2 
weeks labeling period in adult B6 mice. At the end of the labeling period, BrdU labeling 
was measured in naive and memory-phenotype CD8 T cells in the bulk population as 
well as cells isolated using a mixture of peptide/MHC tetramers (comprised  of B8R/Kb, 
M57/Kb, and HSVgB/Kb). As was expected based on previous studies62, a fraction of 
bulk naive CD8 T cells incorporated a low level of BrdU (Fig. 5A), which has been 
ascribed to labeling during thymic development62. A larger cohort of bulk memory-
phenotype CD8 T cells showed BrdU incorporation, and BrdU staining was of greater 
intensity, suggestive of active proliferation during the labeling period. Importantly, 
similar patterns of BrdU incorporation were observed for the tetramer-staining cells 
isolated by tetramer enrichment (Fig. 5), suggesting that VM cells undergo basal 
proliferation, albeit at a slightly lower rate than observed in the bulk memory-phenotype 
CD8 T cell pool (Fig. 5B). Overall, these data suggest VM cells, similar to conventional 
TM CD8 T cells, are advanced in their cell cycle status and capable of long-term 
maintenance (involving basal proliferation). 
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Figure 2-5.  Basal proliferation of VM cells at steady state. Normal adult B6 
mice were labeled with BrdU for 14–16 d, or were maintained in parallel without 
BrdU exposure (control). Spleen and lymph node cells were isolated and stained 
for cell surface markers and intracellular BrdU (for the bulk population), or were 
first subjected to tetramer enrichment (using a mixture of B8R/Kb, M57/Kb, and 
HSVgB/Kb tetramers) prior to surface and intracellular staining with Abs. Events 
were gated on bulk or tetramer+ve naive and memory-phenotype CD8 T cells, as 
indicated. (A) Representative data. Vertical blocks are overlaid on the contour 
plots to highlight the different levels of BrdU staining on naive and memory T 
cells. The numbers on the plots indicate the percentage of total BrdU+ve cells 
(regardless of staining intensity). (B) Compiled data on the percentage of 
BrdU+ve cells among the naive and memory-phenotype cells among bulk and 
tetramer+ve CD8 T cells. Data are from three experiments deriving from two 
independent BrdU-labeling cohorts.
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VM CD8 T cells display differential cytokine producing capacity to “true” memory 
CD8 T cells. 
T-box transcription factors are known to serve as positive regulators of IFN-γ 
production54,55,63.  Therefore, we next examined IFN-γ production by naïve, VM and TM 
populations from Vβ5 mice, following peptide/MHC (Ova peptide) stimulation in vitro 
for 2 or 5 hours.  Since TCR engagement induces production of TNF-α in both naïve and 
memory CD8 T cells32,64, we gated on TNF-α+ cells to identify the antigen responsive 
population:  At 5 hours, this population represented around 80% of tetramer-binding cells 
(Fig. 6A, allowing us to accurately assess whether TNF-α producing cells also 
synthesized IFN-γ).  As expected32,54,55, few responding naïve phenotype CD8 T cells 
made IFN-γ by 5 hours, while nearly all TM cells produced this cytokine at 2 hours (Fig. 
6B, C).  Significantly, IFN-γ production by the VM CD8 T cell population was much 
weaker than that of TM cells at either time point, and was only marginally increased over 
induction in the naïve population at limiting antigen doses (Fig. 6B, C).  Furthermore, 
production of TNF-α at 2h of stimulation was significantly greater in the TM pool 
compared to either VM or naïve cells (Fig. 6A).  On the other hand, overall dose 
sensitivity was unchanged in these populations, arguing against differences in functional 
avidity. Such results extend and confirm our earlier in vivo studies27 and suggest that the 
VM pool, despite expressing high levels of relevant T-box factors (Fig 2A, B), is less 
competent for rapid IFN-γ production, compared to TM cells.  
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Figure 2-6. Proinflammatory cytokine production in VM, naïve and TM Vβ5 CD8 T 
cells upon in vitro stimulation with OVA peptide. (A) Percentage of TNF-α producing 
cells among Ova peptide specific Vβ5 CD8 T cells upon in vitro stimulation of OVA 
peptide (10-7M - 10-10M) for 2 or 5 hours, corrected for the frequency of Ova/Kb 
tetramer+ cells in an unstimulated sample (i.e. % of TNF-α producing CD8 T cells ÷ % 
of Ova/Kb tetramer positive CD8 T cells).  (B) IFN-γ production in VM, naïve and TM 
Vβ5 CD8 T cells upon in vitro stimulation with OVA peptide.  Data show the frequency 
of TNF-α+, IFN- γ+ cells within the total responsive (TNF-α+) pool. The response was 
measure at 2 or 5 hours after simulation with titrated OVA peptide doses (10-7M - 10-
10M).  (C) IFN-γ production evaluated at 2 and 5 hours after 10-7M OVA peptide 
treatment, and shown in comparison with CD44 expression levels. The graph shows 
compiled data from 4 independent experiments and lines show mean +/- SD. Statistical 
significance between VM and TM is indicated (***, p<0.001; **, p<0.01; while “n.s.” 
(“not significant”) is used to denote P-values >0.05, Student t test)  
 
 
   32 
 Taken together, these data support the concept that the VM population is similar 
to antigen-primed memory (TM) cells in some characteristics (elevated T-box factor 
expression, cell cycle position and long-term maintenance) yet not others (rapid, efficient 
IFN-γ production).   
 
VM CD8 T cells preferentially expand during the effector phase of primary immune 
response compared to naïve CD8 T cells. 
Previous studies showed that lymphopenia-induced memory cells expanded more 
quickly than naïve T cells during an antigen specific immune response32,40.  However, 
such studies have not been reported for the naturally occurring VM population -- due in 
large part to the scarcity of VM cells specific for a given antigen in normal polyclonal 
mice.  Use of the Vβ5 system allowed us to directly compare naïve and VM cell 
responses to cognate antigen.  Specifically, we used a dual adoptive transfer system (Fig. 
7), permitting characterization of each population responding in an identical environment 
throughout the immune response.  To avoid TCR stimulation, transferred cells were not 
stained with OVA/Kb-tetramer (although an aliquot from each sorted sample was 
assessed for tetramer binding, to determine the antigen-specific precursor frequency). 
During early stage of the infection (0, 5 hours and 3 days post infection), we performed 
Ova/Kb tetramer enrichment, to track the rare antigen specific donor CD8 T cells. 
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Figure 2-7.  In vivo adoptive transfer of Vβ5 VM CD8 T cells with Naïve or TM. 
Experimental schematics. To directly compare VM to Naïve or TM during the cognate 
antigen specific immune response in vivo, congenically distinct VM (CD44high) and 
Naïve (CD44low) CD8 T cells were sorted from unprimed Vβ5 tg mice. Vβ5 TM CD8 T 
cells were generated in wild type B6 recipients by adoptive transfer of unprimed total 
Vβ5 CD8 T cells and subsequent infection of attenuated (ActA) LM-OVA for at least 
50days, and sorted with congenic marker (CD45.1). Then, number of Ova/Kb specific 
CD8 T cells was determined by Ova/Kb-tetramer staining, and VM CD8 T cells were co-
transferred with Naïve or TM CD8 T cells in 1:1 ratio (include 300-500 Ova/Kb specific 
CD8 T cells in each population) into recipients, which were subsequently infected with 
LM-OVA ActA. Ova/Kb-tetramer and relevant congenic markers determined the Ova 
antigen specific cells within each population. For inducing the secondary immune 
response, mice were infected with virulent LM-OVA at day 50 post primary infection. 
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 Initial engraftment of both donor populations was similar (Fig. 8A), but by day 3 
of LM-OVA infection, VM CD8 T cells had undergone significant expansion while the 
naïve pool had not increased in number, such that the VM-derived population 
outcompeted their naïve counterparts by more than 10-fold (Fig. 8A).  The magnitude of 
this competitive advantage was rapidly lost however, as the response progressed through 
days 5 and 8 post-infection (Fig. 8A), and at memory time points both VM- and naïve-
derived populations were observed in similar numbers.  Hence, these data suggest a 
dramatic advantage for the VM population early in the immune response to infection, 
while naïve cells “catch up” by the peak of expansion.  To analyze very early antigen 
encounter, we examined CD69 upregulation at 5 hours post infection.  Notably, the 
Ova/Kb tetramer staining VM population exhibited significantly greater CD69 induction 
than naïve cells of the same specificity (Fig. 8B).  Weaker CD69 upregulation was 
observed on tetramer-negative VM cells, though whether this represents low-grade non-
specific activation or the response to other LM epitopes is unclear (Fig. 8B). We also 
examined the secondary response of cells derived from VM and naïve precursors 
(stimulated by infection with virulent LM-OVA at day 50) (Fig. 7).  In contrast to the 
primary response, no numerical advantage of the VM-derived population was observed at 
day 3 or 5 of the recall response, which showed characteristically rapid kinetics (Fig. 8C).  
Such findings suggest that differences in the initial response of VM versus naïve CD8 T 
precursors are not carried forward into the memory pool they produce after antigen 
encounter. 
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Figure 2-8.  VM CD8 T cells out-compete their naïve counterparts during the 
expansion phase of the primary immune response. (A) At the indicated time points 
following LM-OVA infection, Ova/Kb tetramer+ve cells derived from VM and naïve 
Vβ5 donors in the spleen and superficial lymph nodes were enumerated.  Data are shown 
as absolute numbers or ratio between VM and naïve derived cells.  (B) The frequency of 
CD69 expressing Ova/Kb-tetramer + or Ova/Kb-tetramer – Vβ5 CD8 T cells was 
determined 5 hours after LM-OVA infection.  Data show CD69 expression by paired 
samples of naïve and VM cells in the same recipients.  (C) Number of Ova/Kb specific 
VM and naïve Vβ5 CD8 T cells during secondary immune respond against LM-OVA.  
For all experiments, the data are compiled from 3 independent experiments except day 22 
p.i. (panels A) which were derived from 2 independent experiment (6 mice total).  Line 
graphs show mean +/- SD and statistical significance is indicated (***, p<0.001; *, 
p<0.05, while “n.s.” (“not significant”) is used to denote P-values >0.05, Student t test). 
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This early proliferative advantage of VM cells could potentially be an artifact of 
the Vβ5 system, or specific to LM infections.  Hence, we tested distinct model systems in 
which dual adoptive transfers were performed using naïve and VM populations from 
normal, polyclonal B6 CD8 T cells (Fig. 9A).  In order to compensate for the low 
precursor frequency for specific antigens, we explored the response to multiple Kb-
restricted epitopes during a response to LM, or examined the response to an 
immunodominant epitope (B8R) following infection with vaccinia virus (Fig. 9A).  
Similar to our findings with Vβ5 CD8 T cells, antigen specific cells derived from 
polyclonal VM population were present at elevated numbers compared to those derived 
from the naïve subset (Fig. 9B, C).  These data suggest that VM CD8 T cells activate 
more rapidly and expand more quickly than naïve CD8 T cells of the same specificity, 
leading to an initial (but transient) advantage of the VM pool, during the primary immune 
response. 
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Figure 2-9.  VM CD8 T cells out-compete naïve counterparts for acute phase of 
immune response.  (A) Experimental schematic.  Congenically distinct polyclonal 
CD44high and CD44low CD8 T cells (2x106 cells of each population) from unprimed 
mice were co-transferred in 1:1 ratio into congenic wild type host, which were 
subsequently immunized with attenuated LM strains (LM-OVA-B8R and LM-OVA-
HSVgB) (B) or Vaccinia virus (VV-WR) (C).  (B) shows the number of tetramer cocktail 
(Kb-OVA/Kb-B8R/Kb-HSVgB) positive CD8 T cells within each donor population (and 
host cells) in the spleen 4 days post infection after LM-OVA ActA infection.  Data are 
compiled from 2 independent experiments (3 mice for each infection)  (C) The numbers 
of donor and host Kb-B8R tetramer+ cells in the spleen and ovary of day 4 VV-WR 
infected recipients are shown.  Data are compiled from 3 independent experiments and 
lines show mean +/- SD. 
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VM CD8 T cells preferentially differentiate into short-lived effector phenotype cells 
and Central Memory cells following priming. 
At the effector stage, naïve- and VM-derived cells showed similar capacity for 
cytokine production and upregulation of T-bet and Eomes (Fig. 10A, B), suggesting 
similar acquisition of effector functions and characteristics.  However, the finding that 
initial expansion advantage of VM cells is not sustained (Fig. 8A) might suggest that a 
greater fraction of these cells become “short-lived effector cells” (SLEC), and hence 
succumb to apoptotic death as the expansion phase ends65.  Indeed, we observed a modest 
but significant elevation in the frequency of KLRG1+ CD127lo SLEC phenotype cells 
among VM-derived cells at the effector stage (Fig. 11A), while cells derived from the 
naïve donor population showed a reciprocal enrichment for KLRG1- CD127hi memory 
phenotype cells in the late effector and memory phases (Fig. 11B). Once again, these 
differences between VM and naïve responder cells were only detected following priming:  
in the recall response, progeny of both donors gave rise to phenotypically similar 
secondary effector populations (Fig. 10C, D).   
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Figure 2-10.  Phenotypic and functional comparison between VM and naïve CD8 T 
cells during primary and secondary LM infection.  (A,B) Responder cells derived 
from co-transferred naïve and VM Vβ5 CD8 T cells were assayed at day 5 following 
primary LM-OVA infection.  Pro-inflammatory cytokine (IFN-γ and TNF-α) production 
was determined for donor populations (identified by congenic markers) (B), and 
expression of T-box transcription factors (T-bet and Eomes) was determined for OVA/Kb 
tetramer+ donor (C).  Data are representative of 2 experiments (6 mice total).  (C,D) 
Phenotype of VM- and naïve- derived Vβ5 CD8 T cells at the indicated times during a 
recall response, induced by virulent LM-OVA infection.  Data are representative of 3 
independent experiments. 
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Figure 2-11.  Comparisons of phenotype and peripheral residency between VM and 
naïve CD8 T cells during primary LM infection.  (A,B) Short-lived effector (KLRG1+ 
CD127lo) and memory precursor (KLRG1- CD127hi) phenotype of responding VM and 
naïve CD8 T cells, during effector and memory phase of LM infection.  Frequencies of 
phenotypic subsets were determined on Ova/Kb-tetramer+ donor Vβ5 CD8 T cells at the 
indicated times post infection.  Line graphs show mean +/- SD. (C) Central memory 
(CD62L+ve) differentiation of responding VM and naïve donor Vβ5 CD8 T cells. The 
frequency of CD62L+ve cells in cotransfered naïve and VM populations is shown. For all 
experiments, data were compiled from 3 independent experiments, except day 22 p.i. (2 
independent experiment; 6 mice total).  Statistical significance between groups is 
indicated (***, p<0.001; **, p<0.01; *, p<0.05, while “n.s.” (“not significant”) is used to 
denote P-values >0.05, Student t test).  
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We also investigated whether the VM population might also be skewed in their 
memory subset distribution.  Two prominent memory sub-populations are CD62L+ 
“Central memory” (Tcm) and CD62L- “Effector memory” (Tem) groups66,67.  While TCM 
typically recirculate through lymphoid sites, TEM are associated with trafficking and 
residency in non-lymphoid tissues.  Hence, we analyzed naïve- and VM-derived cells at 
the memory phase (days 22 and 50) to determine their phenotype and patterns of tissue 
distribution.  Interestingly, VM-derived cells showed a significant enrichment for Tcm 
phenotype cells compared to naïve-derived cells (Fig. 11C). Consistent with this, the 
progeny of naive responder cells were significantly over-represented in non-lymphoid 
tissues (salivary gland and kidney), sites where Tem are typically enriched (Fig. 12).  
 
Figure 2-12. Peripheral tissue distribution of VM CD8 T cells in memory stage. 
Ratio between Ova/Kb-tetramer specific VM and naïve Vβ5 CD8 T cells in indicated 
tissues and blood at 50-60 days post-LM infection.  (Blood contamination in each tissue 
was excluded as described in SI Materials and Methods).  Data were compiled from 3 
independent experiments.  Statistical significance between groups is indicated (***, 
p<0.001; *, p<0.05, while “n.s.” (“not significant”) is used to denote P-values >0.05, 
Student t test).  
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These data argue that, during a primary immune response, VM cells differ from 
naïve cells not only in their response kinetics but by qualitative changes in the generation 
of effector and memory subsets. 
 
VM and TM CD8 T cells show similar response kinetics, but qualitative differences 
in effector differentiation. 
 To this point, our studies had focused on comparing the immune response of VM 
cells to naïve counterparts.  However, studies using lymphopenia-driven memory CD8 T 
cells showed that they are outcompeted by TM cells during an immune response32,41.  To 
investigate this in our studies of spontaneously generated VM CD8 T cells, we again 
performed dual adoptive transfer experiments:  as before, congenically distinct Vβ5 TM 
(generated by adoptive transfer of bulk Vβ5 CD8 T cells into congenic recipients, and 
subsequent LM-OVA infection) and VM cells were sorted and co-transferred into 
recipients, which were then infected with LM-OVA (Fig. 7).  Adoptive transfer 
efficiencies were similar for VM and TM populations (data not shown). 
 At the level of kinetics and magnitude of the response, we observed no significant 
differences between TM and VM populations until the memory phase – at which point 
the TM pool had a slight (but significant) advantage over the VM pool (Fig. 13A). In 
contrast to these mild effects, substantial differences were observed in the differentiation 
of TM and VM-derived cells. Previous studies have shown that secondary immune 
responses (of “true” memory CD8 T cells) generate a population of effector-like CD8 T 
cells that are sustained into the memory phase, and a corresponding underrepresentation 
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of Tcm cells23,68,69. Indeed, we observed high frequencies of KLRG-1+ CD127lo cells, 
and a corresponding deficit in production of KLRG-1- CD127hi memory cells, for the 
population generated from the TM pool (Fig. 13B, C).  In contrast, the responder cells 
derived from the VM pool showed much more efficient production of KLRG-1- CD127hi 
memory-phenotype cells.  Furthermore, while responding TM cells showed inefficient 
production of CD62L+ (i.e.  Tem) phenotype memory cells, the VM-derived pool 
produced a significantly larger CD62Lhi subset (Fig. 13D), echoing similar studies using 
lymphopenia-induced memory OT-I CD8 T cells41.  It is important to note, however, that 
the bias of VM-derived cells toward the TCM phenotype did not result in their more 
efficient maintenance, compared to the TM-derived pool (Fig. 13A).  Overall, our 
findings suggest that VM CD8 T cells expand similarly to “true” memory CD8 T cells, 
yet display substantially altered differentiation characteristics.   
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Figure 2-13.  VM and TM CD8 T cells show similar kinetics in proliferation, but 
differential effector differentiation.  (A)  Graphs show the number of co-transferred 
Ova/Kb specific VM and TM Vβ5 CD8 T cells in the spleen and superficial lymph nodes 
at the indicated times post LM-OVA infection.  (B,C,D) Phenotypic comparison between 
responding VM and TM CD8 T cells, gated on OVA/Kb tetramer+ donor cells at the 
indicated days post LM-OVA infection.  Graphs show compiled data from 3 independent 
experiments and lines show mean +/- SD. Statistical significance between groups is 
indicated (***, p<0.001; **, p<0.01, while “n.s.” (“not significant”) is used to denote P-
values >0.05, Student t test). 
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VM cells provide potent antigen-specific protective immunity against LM infection. 
Our findings indicate that VM cells display only some characteristics of true 
memory cells.  This raised the question of whether VM cells would be capable of 
mediating protective responses against infection.  Our previous studies showed that 
lymphopenia-induced homeostatic memory OT-I CD8+ T cells were capable of Listeria 
monocytogenes control32,33, and a recent report showed similar potent protection by the 
VM population that arises spontaneously in intact OT-I mice45.  However, it was not clear 
whether these findings would correspond to the polyclonal Vβ5 CD8 T cells studied here.  
In particular, the poor induction of IFN-γ following TCR stimulation of Vβ5 VM (Fig. 
6B, C) was noteworthy, since this factor is critical in control of several pathogens, 
including Listeria70.  Furthermore, several studies have suggested that memory-
phenotype CD8 T cells from unimmunized mice have regulatory functions46-50,71:  hence, 
the VM population might inhibit, not elicit pathogen control.  To explore this issue, we 
performed studies to compare VM, naïve and TM CD8 T cells for protection against 
virulent LM-OVA infection.  Cells were isolated and sorted as before, but populations 
were transferred into separate hosts, and were designed to include ~2x104 Ova/Kb 
tetramer+ cells.  Host mice were subsequently challenged with a LD50 dose of virulent 
LM-OVA (or wild type LM) and on day 5 after infection, CFU in the spleen and liver 
were measured, and the expansion of donor CD8 T cells was assayed as in previous 
reports.    
Similar to other studies using OT-I TCR transgenic CD8 T cells32,33,45, naïve Vβ5 
CD8 T cells offered little protection against LM-OVA infection, while antigen-primed 
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TM cells induced significantly greater bacterial control, in both spleen and liver (Fig. 
14A).  Remarkably, the VM population was at least as potent as TM cells in mediating 
LM-OVA clearance (Fig. 14A), suggesting that spontaneously arising VM cells can 
provide efficient protective immunity.  Given the low number of donor cells transferred 
(2x104 cells, corresponding to ~2x103 cells with a calculated 10% take), these data 
suggest that, like the TM population, VM cells exhibit potent and efficient protective 
capacity.  Since we could not purify Ova/Kb specific VM cells prior to transfer (which 
would necessarily have involved staining with peptide/MHC tetramers, possibly affecting 
functional responses), it was possible that bacterial control by the polyclonal VM 
population involved responses to other LM epitopes and/or non TCR specific responses.  
For example, we previously showed that VM cells (like TM) elaborate IFN-γ when 
stimulated with IL-12 and IL-18, in the absence of TCR engagement27,72-74.  In order to 
test whether protection in our studies was antigen specific we conducted parallel 
experiments using non-recombinant (WT) LM infection.  In this situation, none of the 
transferred Vβ5 populations provided protection in the spleen, and LM control in the liver 
was insubstantial (Fig. 14A).   
All the transferred populations underwent vigorous expansion after LM-OVA 
infection, with both memory cell populations reaching ~1,000 fold increase in number 
and significantly out-expanding naive CD8 T cells (Fig. 14B).  In our earlier studies 
using attenuated LM-OVA, there was little difference between expansion of naïve and 
VM cells at this time point (day 5), hence these findings may relate to use of virulent 
LM-OVA for the protection assays.  In keeping with our other findings, we found that the 
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frequency of KLRG1+CD127lo effector cells was significantly different for each donor 
population, following the hierarchy TM > VM > naïve (Fig. 14C).  Hence, these 
phenotypic characteristics of each responsive pool were preserved during the response to 
virulent LM-OVA.   
These data suggest that, despite their distinct characteristics in comparison with 
both TM and naïve CD8 T cells, the VM pool can provide potent and antigen-specific 
protective immunity against pathogen infection.  
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Figure 2-14.  VM cells provide potent antigen-specific protective immunity against 
LM infection.  Naïve, VM and TM Vβ5 CD8 T cells were sorted and approximately 2 x 
104 Ova/Kb specific cells were singly transferred into unprimed recipients.  Host mice 
were infected the next day with virulent LM-OVA or wild type LM (LM-WT).  (A) CFU 
of indicated LM strains in the spleens and livers of the recipient mice 5 days after 
infection.  (B) Number of Ova/Kb specific CD8 T cells and (C) Frequency of 
KLRG1+CD127- CD8 T cells in the spleens of recipient mice at day 5 post LM-OVA 
infection.  Graphs show compiled data from 4 independent experiments for LM-OVA 
infection and 2 independent experiments for LM-WT infection and lines show mean +/- 
SD.  Statistical significance between groups is indicated (***, p<0.001; **, p<0.01; *, 
p<0.05, while “n.s.” (“not significant”) is used to denote P-values >0.05, Student t test).
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Discussion 
 
Studies over the last dozen years have shown that memory T cells are not 
exclusively generated through encounter with foreign antigen, but can also be induced 
through homeostatic pathways12,24,28-31.  Furthermore, we and others reported that a 
population of memory-like cells arise spontaneously in unimmunized mice, and that such 
cells constitute a small but significant fraction of the precursors specific for a given 
foreign antigen, prior to priming26,27.  Data in this report suggest that the functional 
properties of these “virtual memory” cells lies in between those of naïve and “true” 
memory cells.  The VM pool differed from naïve cells (and resembled TM) in their early 
in vivo expansion, elevated expression of T-box factors and position in G1 stage of the 
cell cycle.  Perhaps most importantly, VM cells resembled true memory cells in highly 
efficient, antigen-specific control of the pathogen Listeria monocytogenes.  On the other 
hand, we found that the VM pool differed markedly from TM cells in their preferential 
differentiation toward the Tcm phenotype following antigen encounter in vivo, and that 
VM cells were much less efficient at rapid production of IFN-γ following TCR 
stimulation.  The latter findings differ slightly from our initial study, which had 
concluded that VM cells behaved like naïve cells in their slow induction of IFN-γ 
following TCR stimulation27.  Since VM cells show strong expression of both T-box 
factors (T-bet and Eomes), and evidence of Tc1 differentiation (e.g. robust CXCR3 
expression), their inefficient production of IFN-γ is unexpected and intriguing.  Although 
T-bet clearly requires other factors (such as the Jmjd3 histone demethylase for chromatin 
remodeling of target loci)75, such studies show good concordance for multiple T-bet 
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targets, including CXCR3 and IFN-γ.  It is possible that this trait reflects altered T-
bet/Eomes expression levels (Fig. 2A), although both T-box factors are reported to be 
capable of promoting IFN-γ expression.  Hence the selective deficiency in IFN-γ 
induction appears unique to VM cells.  
Taken together, these data suggest homeostatic pathways only partially substitute 
for antigen encounter in programming full memory differentiation (although, 
significantly, this includes the capacity to mediate protective immunity against some 
infections).  Interestingly, our results differ from previous studies on the properties of 
homeostatic memory cells generated in severely lymphopenic hosts.  We and others 
found that such cells rapidly produce IFN-γ after TCR stimulation at levels similar to true 
memory cells32,40, while our current data show that the VM pool is substantially 
compromised in this response (Fig. 6B, C).  On the other hand, using OT-I T cells, 
Cheung et al reported that true memory cells exerted a substantial numerical advantage 
over lymphopenia-induced homeostatic memory cells during a competitive in vivo 
responses to LM-OVA infection41:  In contrast, we found minimal differences in numbers 
of TM and naturally occurring VM during a similar response (Fig 13A).  These 
discrepancies may reflect the distinct pathways for homeostatic memory generation 
entailing different intensities or mechanisms of response13,24.  The naturally occurring 
VM pool arises slowly over the weeks following birth (as the T cell compartment is 
filling)26, in a process involving IL-15 presentation by CD8α+ dendritic cells45.  In 
contrast, acute lymphopenia provides a stronger and more sustained homeostatic signal, 
potentially leading to altered differentiation.  Regardless, our current report suggests that 
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the functional properties of naturally arising VM cells are not accurately reflected in 
studies (including our own)32 on homeostatic memory cells artificially produced in 
severely lymphopenic hosts.  
Interestingly, VM CD8 T cells preferentially differentiated toward Tcm 
phenotype after antigen priming.  This was especially notable in the comparison between 
TM and VM – since, as expected, restimulated TM cells showed a strong bias toward 
Tem differentiation.  Similar findings were reported in comparison of true and 
lymphopenia-induced memory OT-I cells41.  However, this bias toward Tcm 
differentiation was detected even when VM were compared to naïve precursors, which 
was unexpected.  While the basis for this focused differentiation is unclear, a 
consequence is that VM cells would contribute disproportionately to the Tcm pool.  Since 
recent studies have suggested that Tcm cells are especially important for control of 
chronic viral infections76, these findings may suggest a particular relevance of VM in 
mounting rapid, effective responses against such pathogens.   
 
 
Figure 2-15. Comparison of immunologic caracters among Naïve, VM and TM CD8 
T cells. 
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Materials and methods 
 
Mice 
Female C57BL/6 (CD45.2/Thy1.2), B6.SJL (CD45.1/Thy1.2) and B6.PL 
(CD45.2/Thy1.1) mice (6-7 weeks old) were purchased from the Jackson laboratory and 
the National Cancer Institute.  Female B6.SJL mice were bred with male B6.PL to 
generate B6.PL.SJL (CD45.1/CD45.2/Thy1.1/Thy1.2) mice.  Vβ5 TCR transgenic mice 
were maintained on a B6.SJL background, or bred with C57BL/6 mice to generate 
Vβ5/B6xB6.SJL (CD45.1/CD45.2).  All mice were maintained in specific pathogen-free 
conditions.  All experimental procedures were approved through the University of 
Minnesota IACUC. 
 
In vivo generation of “true” memory Vβ5 CD8 T cells 
CD45.1 Vβ5 CD8 T cells (1 x 106) were negatively enriched from spleen and 
superficial lymph nodes, using a CD8α+ isolation kit (Miltenyi Biotec) and injected 
intravenously (i.v.) into CD45.2 congenic C57BL/6 mice.  Mice were immunized 24 
hours later by i.v. injection of 3 x 106 colony-forming units (CFU) of L.  monocytogenes 
strain expressing OVA (LM-OVA ActA attenuated) (a kind gift of Hao Shen, University 
of Pennsylvania School of Medicine).  In vivo generated memory T cells were detected 
with fluorescent–labeled anti-CD45.1 (eBioscience) 30–60 days after priming. 
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Adoptive transfer and Immunization 
Combinations of CD45 and CD90 alleles were chosen to allow discrimination of 
co-transferred naïve, VM and TM populations.  For Vβ5 CD8 T cell experiments, spleen 
and superficial lymph nodes were harvested from unprimed Vβ5 tg mouse strains 
(CD45.1 or CD45.1/CD45.2), and/or mice carrying primed, memory Vβ5 CD8 T cells (as 
a source of TM cells).  Collagenase digestion was performed on tissues, and CD8 T cells 
were negatively enriched by CD8α+ isolation kit (Miltenyi Biotec).  To avoid pre TCR 
stimulation, cells were sorted by CD8, CD44 and relevant congenic marker antibodies 
without Ova/Kb-tetramer staining using a FACSAria (BD Biosciences).  After the 
sorting, the number of antigen specific cells within each population was determined using 
Ova/Kb-tetramer staining of an aliquot from the sorted samples.  Next, 300-500 Ova/Kb-
tetramer positive cells of the indicated phenotype were mixed 1:1 and co-transferred (i.v.) 
into naïve C57BL/6 (CD45.2/Thy1.2) hosts, which were infected with 3 x 106 CFU LM-
OVA ActA one day later.  To induce recall immune response, mice were infected with 1 
x 105 CFU of virulent LM-OVA.  For polyclonal CD8 T cell transfer, VM and naïve CD8 
T cells were sorted from unprimed C57BL/6 (CD45.2/Thy1.1) and B6.SJL 
(CD45.1/Thy1.2) mice (as described above), and 2 x 106 cells of each population were 
mixed 1:1 and co-transferred (i.v.) into naïve (B6.PL x B6.SJL)F1 hosts 
(CD45.1/CD45.2/Thy1.1/Thy1.2).  The recipient mice were infected with 2x106 PFU of 
Vaccinia virus (VV-WR) or a cocktail of attenuated recombinant LM strains (LM-OVA-
B8R, LM-OVA-HSVgB) one day later.  Attenuated LM-OVA-B8R and LM-OVA-
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HSVgB strains were provided from Dr.  Ross M.  Kedl (University of Colorado) and Dr.  
SingSing Way (University of Minnesota) respectively. 
 
Flow cytometry  
For determining surface phenotype, cells were isolated from spleen and 
superficial lymph nodes, and stained with the antibodies specific for following molecules: 
CD3e (145-2C11), CD4 (GK1.5), CD8 (53-6.7), CD44 (IM7), CD69 (H1.2F3), KLRG1 
(2F1), CD62L (MEL-14), CD122 (TMb1), CD127 (A7R34), CD45.1 (A20), CD45.2 
(104), Thy1.1 (HIS51), Ly-6C (HK1.4), CD49d (R1-2) and CXCR3 (CXCR3-173).  For 
detecting foreign antigen specific CD8 T cells, fluorochrome (PE or APC) labeled 
Ova/Kb (SIINFEKL), B8R/Kb (TSYKFESV) and HSVgB/Kb (SSIEFARL) tetramers 
were generated as previously described77,78 and used to stain cells (30 minutes at 4°C), 
simultaneously with other surface markers.  In some experiments tetramer binding cells 
were enriched by a MACS based pull-down assay, as previously described in detail27.  
For intracellular transcription factor staining, stained cells with surface antibodies were 
fixed and permeabilized with Foxp3 Fixation/Permeabilization solution (eBioscience), 
and stained with antibodies to T-bet (4B10) and Eomesodermin (Dan11mag) for 1 hour at 
4°C in Permeabilization Solution.  Flow cytometry was performed on LSRII or Fortessa 
instruments (BD), and analyzed using FlowJo analysis software.   
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In vitro stimulation and IFN-γ production assay 
Naïve and memory Vβ5 tg splenocytes were incubated with various doses (10-6-
10-10M) of OVA peptide (SIINFEKL), and Golgi Plug (BD Biosciences) for 2-5 hours.  
Cells were then surface stained, fixed and permeabilized with BD Cytofix/Cytoperm (BD 
Biosciences), and intracellularly stained for IFN-γ (XMG1.2) and TNF-α (MP6-XT2.2) 
in BD Perm Wash Buffer (BD Biosciences), similarly to our previous studies32.  
 
Cell cycle analysis 
Cell cycle analysis was performed using staining for DNA and RNA with DAPI 
and pyronin Y, respectively.  Negatively enriched CD8+ T cells were obtained using a 
CD8α+ T Cell Isolation Kit II, mouse (Miltenyi Biotec) from unprimed mice (for naïve 
and VM populations) and immunized animals (for TM cells).   Cells were surface stained 
and then fixed/permeabilized with FoxP3/Transcription Factor Staining Buffer 
(eBioscience) overnight.  The cells were then incubated with 5 µg/ml DAPI in 200 µl 
FACS buffer (2% FCS, 0.1% NaN3) for 1 hour and, without further washing, an equal 
volume of 3 µg/ml pyronin Y diluted FACS buffer was added to each sample 5 minutes 
before flow cytometric analysis.   
 
Quantitative real-time PCR 
CD44high memory phenotype, CD44low naïve phenotype and TM Vβ5 CD8 T 
cells were sorted on a FACSAria (BD bioscience), as described above.  RNA was 
isolated by RNeasy microkit (Qiagen), and cDNA was generated using SuperScript III 
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Reverse Transcriptase (Life technologies).  Real-time RT-PCR was performed using the 
ABI 7700 sequence detection system, with SYBR Green PCR Master Mix (Applied 
Biosystems).  Primer sequences are available upon request. 
 
Resident memory CD8 T cell (Trm) determination 
To exclude blood circulating CD8 T cells from tissue parenchymal Trm 
populations, we performed intravascular staining method with fluorescently labeled anti-
CD8 antibodies as previously described79.  Briefly, mice were injected i.v.  with 
fluorescently labeled anti-CD8α antibody on 50~60 days post primary infection of LM-
OVA.  Then, the mice were bled and sacrificed 3 minutes later and perfused for remove 
residual blood.  Spleen, kidney, salivary glands were harvested, and single cell 
suspensions were prepared by collagenase treatment.  Tissue parenchymal CD8 T cells 
were stained by using a distinct fluorochrome conjugated CD8α antibody that allows 
distinguish CD8β stained blood circulating CD8 T cells. 
 
Listeria monocytogenes protection assays 
To assess protective immune function of VM, naïve, and TM Vβ5 CD8 T cells, 
each population was sorted as described above and an inoculum containing ~2 x 104 
Ova/Kb specific cells (determined by staining an aliquot of sorted cells with Ova/Kb 
tetramer) was adoptively transferred into unprimed C57BL/6 host.  In these experiments, 
populations were transferred singly, not co-transferred.  One day later, mice were 
infected with 8 x 104 CFU of virulent LM-OVA or 1 x 104 CFU of virulent wild type LM 
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(the ~LD50 of each strain).  On day 5 after infection, CFU of LM in the spleen and liver 
were measured as previously described32,33.  For determining antigen specific expansion 
of host and transferred CD8 T cells, splenocytes from the infected mice were counted and 
stained with Kb-OVA tetramer. 
 
BrdU incorporation assays 
Mice were injected i.p. with 1 mg BrdU (in PBS), and then maintained on BrdU-
laced drinking water (0.8 mg/ml, with 2% sucrose to offset bitterness) for 14–16 d. For 
bulk analysis, thymocytes and pooled spleen and lymph node cells were prepared and 
stained for surface markers, followed by fixation, permeabilization, and intracellular 
staining for BrdU following manufacturer’s instructions (BD Biosciences). In parallel, 
the remaining spleen and lymph node sample was subject to tetramer pulldown (using a 
mixture of PE-labeled B8R/Kb, M57/Kb, and HSVgB/Kb tetramers) prior to staining for 
surface markers and BrdU. 
 
Statistics   
A two-tailed, paired or unpaired, Student’s t-test was performed using Prism 
(GraphPad Software Inc.).  In some figures, plotted data represent means ± SD, and P-
values are represented as follows:  ***, p<0.001; **, p<0.01; *, p<0.05, while “n.s.” 
(“not significant”) is used to denote P-values >0.05. 
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Chapter 3 
Role of KLF2 in effector CD4+ T cell lineage commitment 
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Germinal center follicular helper T cells (GC-Tfh) are essential for efficient B cell 
responses, yet the factors that regulate differentiation of this CD4+ T cell subset are 
incompletely understood. We show that the KLF2 transcription factor serves to restrain 
GC-Tfh generation. Downregulation of the trafficking molecule S1PR1 (a KLF2 target) 
is required for GC-Tfh establishment. In addition, KLF2 drives expression of Blimp-1, 
which represses Bcl-6 and thereby impairs GC-Tfh differentiation. KLF2 also promotes 
expression of T-bet and Gata-3 and can enhance Th1 differentiation.  Hence, our data 
indicate KLF2 is pivotal for coordinating CD4+ T cell differentiation through two 
distinct and complementary mechanisms: via control of T cell localization, and by 
regulation of lineage-defining transcription factors. 
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Introduction 
 During the immune response toward foreign antigens, the germinal center (GC) 
reaction represents a central mechanism for generating high affinity antibodies of diverse 
isotypes80. Fundamental in this process is the activity of follicular helper CD4 T cells 
(Tfh), which coordinate generation of the germinal center, initiate help for antigen 
specific B cells, and promote selection of germinal center B cell clones that have 
developed enhanced antigen recognition through somatic hypermutation80-83. 
Characteristic features of Tfh include expression of ICOS, PD-1, the chemokine receptor 
CXCR5 and the cytokine IL-21, and these molecules are key for Tfh generation and 
function80-83. Cells with a Tfh phenotype accumulate around and enter B cell follicles, 
while cells that localize within GC (i.e. GC-Tfh) are characterized by high levels of 
CXCR5, PD-1 and Bcl-680-83. Migration and retention of GC-Tfh in the GC depends on 
CXCR5 and the sphingosine-1-phosphate receptor S1PR284. Downregulation of CCR7 is 
also critical for Tfh accumulation in the follicle and normal GC responses85, however 
other factors that negatively regulate Tfh trafficking are not well defined.  
Multiple transcription factors, including c-Maf, Batf, Irf4, STAT1, STAT3 and 
Ascl2 are involved in development and function of Tfh81,83,86, but maintenance and 
differentiation of Tfh to the fully mature GC-Tfh stage critically requires expression of 
Bcl-681-83. The Tfh differentiation pathway is opposed by other factors, the best studied of 
which is Blimp-1. Bcl-6 and Blimp-1 are mutually antagonistic, making the balance in 
expression of these two factors a critical element in determining helper T cell fate. IL-2R 
signaling impairs Tfh generation in a mechanism involving Blimp-1 and STAT587-90. 
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Furthermore, the factors Foxo1 and Foxp1 both restrain Tfh generation, although the 
mechanisms involved are not fully defined91-93. Activated CD4+ T cells that do not 
mature into Tfh may join one of several alternative “non-Tfh” subsets (including Th1, 
Th2, Th17 and Treg) that are thought to not localize into the germinal center. Key 
transcription factors for several of these alternative fates are blocked by Bcl-681,83,94, 
further establishing this factor as central to reinforcing Tfh differentiation.  
Hence, in order to effectively participate in the germinal center response, Tfh 
must a) migrate into the B cell follicle and reside in the GC; b) acquire specific functional 
properties needed for effective B cell help; and c) exclude alternative differentiation 
fates. It is unclear, however, whether these three aspects are coordinately regulated, and if 
so what transcription factors are involved in that control.  
The transcription factor KLF2 is critical for regulating naïve T cell trafficking, in 
part through promoting expression of CD62L (L-selectin) and S1PR1 – which are critical 
for lymphocyte entry and egress, respectively, from secondary lymphoid tissues7,8,95,96. 
More recently, we reported that reduced KLF2 expression was a prerequisite for effective 
generation of “Resident Memory” CD8+ T cells (Trm) – a population that is prominent in 
non-lymphoid tissues and does not appear to exchange with other sites through 
recirculation via the blood and lymph20. We found that KLF2 induction of S1PR1 was a 
key aspect of this regulation, since forced expression of either KLF2 or S1PR1 served to 
impede generation of Trm20. Those studies suggested that T lymphocyte residence and 
recirculation were characterized by low and high expression of KLF2, respectively. 
Similarly, in order to function in sustained B cell help, GC-Tfh must become a resident 
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population, within the active germinal center. Hence, in this report we explore whether 
KLF2 impacts the capacity of activated CD4+ T cells to become GC-Tfh cells.    
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Results 
GC-Tfh exhibit a KLF2low phenotype 
We initially studied KLF2 expression in antigen specific CD4+ and CD8+ T cells 
responding to lymphocytic choriomeningitis virus (LCMV), using a previously described 
KLF2-GFP reporter mouse strain20,97. In keeping with our earlier findings20, the vast 
majority of effector CD8+ T cells in lymphoid tissues express KLF2 (Fig. 1A), yet we 
noted that KLF2 expression in effector CD4+ T cells was bimodal, with some cells 
expressing KLF2 to similar levels as observed in the CD8+ T cell population, while other 
cells exhibited substantially reduced KLF2 expression (Fig. 1A). We have reported that 
KLF2 downregulation characterized tissue-resident, non-recirculating CD8+ T cells20 and 
the B-cell helper function of Tfh cells obliges them to be retained within the priming 
lymphoid tissue80,81.  Hence we investigated whether KLF2 levels correlated with the Tfh 
populations. Indeed, we found that the KLF2lo subset was highly enriched for cells 
expressing GC-Tfh phenotype (CXCR5hi, PD-1hi and Bcl-6hi) (Fig. 1B). Further 
analysis confirmed that GC-Tfh phenotype cells were KLF2lo, while both Tfh and non-
Tfh populations expressed significantly higher KLF2 levels (Fig. 1C, D). This expression 
pattern was not limited to CD4+ T cells responding to LCMV, since we observed similar 
profiles for polyclonal CD4+ T cells responding to distinct epitopes during acute 
infection with the bacteria Listeria monocytogenes (Fig. 1D). Our findings are consistent 
with gene expression studies that suggested that GC-Tfh populations express lower levels 
of Klf2 and S1pr1 transcripts than non-Tfh92, although those reports did not explore the 
significance of these changes. 
   64 
 
Figure 3-1. KLF2 is down-regulated in GC-Tfh. KLF2-GFP reporter mice were 
infected with LCMV (A-C) or recombinant Listeria monocytogenes expressing the 2W1S 
epitope (LM-2W1S)(B), and analyzed 7 days later.  (A) Antigen-specific splenic CD8+ 
and CD4+ T cells were enriched using Db-GP33 and I-Ab-GP66 tetramers, respectively, 
and monitored for KLF2-GFP expression. Shadow area shows background level of GFP 
signal in non-transgenic wild-type (WT) controls. (B) CXCR5, PD-1 and Bcl-6 
expression is shown for total or KLF2-GFP low LCMV specific CD4+ T cells. (C) 
KLF2-GFP expression by GC-Tfh (CXCR5highPD-1+), Tfh (CXCR5intPD-1-) and non-
Tfh (CXCR5-PD-1-) phenotype cells in I-Ab-GP66 tetramer+ CD4+ T cells from LCMV 
infected mice. Numbers indicate geometric mean fluorescence intensity (gMFI) of KLF2-
GFP expressed in each population. In (D), KLF2-GFP expression levels are shown for 
GC-Tfh, Tfh and non-Tfh phenotype cells in the LCMV specific CD4+ T cells (left), and 
in I-Ab-2W1S tetramer+ and I-Ab-LLO tetramer+ CD4+ T cells LM-2W1S infected mice 
(right).  Data are shown as gMFI minus background gMFI of WT CD4+ T cells. Data are 
from at least three independent experiments with a total of 13 (A, B, C for LCMV 
infection) or 8 (D for LM-2W1S infection) KLF2-GFP reporter mice, and are 
representative of (A, B, C) or accumulated (D) from the independent experiments as 
mean ±s.e.m. Statistical significance was determined using two-tailed t-test: ns, not 
significant (P > 0.05); and ***, P < 0.001.  
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To extend these findings and visualize differences in KLF2 expression in the 
context of lymphoid tissue architecture, we used immunohistochemistry to determine 
KLF2-GFP expression in situ in the draining lymph node following immunization with 
the protein Phycoerythrin (Fig 2). Interestingly, CD4+ T cells that were physically 
localized to the germinal center had significantly lower KLF2 expression than CD4+ T 
cells located in the T cell zone (Fig. 3A, B). Indeed, GFP expression was clearly lower in 
the GC as a whole indicating that both CD4+ T cells and B cells in this zone were 
KLF2lo (Fig. 3B, C). Collectively, these data suggested that the reduced KLF2 
expression is a signature feature of the GC-Tfh population. 
 
 
Figure 3-2. Immunohistochemistry analysis of KLF2-GFP expression in PE specific 
germinal centers. PE specific GCs were determined by GL7+B220+PE+TCRβ- area in 
dLNs (inguinal and lumbar LNs) from mice immunized subcutaneously with PE 
(15µg)/CFA at day 14 post immunization. See Figure 2 for more details.  Gray, DAPI; 
Yellow, B220; Green, TCRβ; Red, PE; Blue, GL7; scale bar, 200µm. The image is 
representative of the staining pattern from three independent experiments. 
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Figure 3-3. Reduced expression of KLF2 by CD4+ T cells in the germinal center 
compared to T cell zone.  Immunohistochemistry analysis of a draining lymph node 
(dLN) from KLF2-GFP reporter mice immunized subcutaneously with Phycoerythrin 
(PE) 14 days earlier. (A) In the left image, the indicated stains were used to identify B 
cell follicles (B220+) and T cell zone (B220-, CD4+), while germinal centers (GCs) were 
identified by GL7 staining (and confirmed by PE co-staining: data not shown).  Two GCs 
are indicated by white arrows.  The right image is the same section, but only the KLF2-
GFP staining signal is shown. (B) The panels show the staining for KLF2-GFP (green) 
and CD4+ (red) for cells in the GC or T cell zone as indicated.  The upper two panels are 
from immunized KLF2-GFP mice, while the lower two panels are from immunized WT 
B6 mice. Gray, DAPI; Purple, B220; Green, KLF2-GFP; Red, CD4; Blue, GL7.  The 
scale bars for the images are shown.  (C) shows the KLF2-GFP fluorescence intensity of 
CD4+ T cells in the GC or T cell zone (using the criteria defined in a,b). Each dot 
represents a single CD4+ T cell and the red bar indicate average fluorescence intensity of 
each group. All experiments were repeated three times with similar results. Graphs show 
accumulated data from three independent experiments as mean ±s.e.m., two-tailed t-test. 
***, P < 0.001. 
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KLF2 and S1PR1 expression throughout the CD4+ T cell response 
To further investigate the regulation and function of KLF2 during CD4+ T cell 
lineage commitment, we developed an adoptive transfer system using TCR transgenic 
CD4+ T cells (TEa), specific for Eα/I-Ab 98. To enhance antigen-specific B cell 
interactions and optimize GC-Tfh cell differentiation80,81, we co-transferred MD4 BCR 
transgenic B cells specific for hen/duck egg lysozyme (HEL/DEL)99, and immunized the 
recipient mice with a conjugate antigen (Eα-DEL) bearing antigens for both TEa and 
MD4 cells (Fig. 4A, B, C).  
With this system, we first defined the detailed kinetics of KLF2 and S1PR1 
expression in vivo, through adoptive transfer of KLF2-GFP20,97 or S1PR1-GFP 
reporter100 TEa CD4+ T cells. At an early activation stage (day 2), primed TEa cells 
uniformly reduced KLF2 and S1PR1 reporter expression in secondary lymphoid organs 
(Fig. 5A, B), in keeping with previous data on KLF2 and S1PR1 downregulation 
following TCR engagement20,35,100. From day 5 of the response, however, non-Tfh 
phenotype cells showed sustained KLF2 re-expression, whereas GC-Tfh phenotype cells 
maintained low KLF2 reporter expression well into the memory phase (day 30). 
CXCR5int, PD-1lo Tfh cells showed intermediate patterns of KLF2 expression (Fig. 5A, 
B). These findings contrast somewhat with the KLF2hi phenotype observed for 
polyclonal Tfh T cells in the response to LCMV or LM (Fig. 1), which may relate to the 
immunization approaches, differences in the frequency of available antigen-specific B 
cells or idiosyncrasies of TEa TCR transgenic T cells101. 
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Figure 3-4. TEa adoptive transfer system. (A) Experimental scheme. To enhance 
antigen-specific B cell help (required for optimal GC-Tfh cell differentiation), TEa TCR 
transgenic CD4+ T cells, specific for an Eα-derived peptide (amino acid residues 52–68) 
in the context of MHC class II molecule I-Ab, were co-transferred with BCR transgenic B 
cells (MD4) specific for hen/duck egg lysozyme (HEL/DEL), and the recipient mice were 
immunized with a conjugate antigen bearing antigens for both TEa and MD4 cells (Eα-
SA-DEL) in CFA. (B, C) Quantification of GC-Tfh differentiation in donor TEa 
populations at various time points with/without MD4 cells. Graphs show accumulated 
data from 3 individual recipients at each time point, represented as mean ±s.e.m., two-
tailed t-test. *, P < 0.05; and ***, P < 0.001. 
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Regardless, S1PR1 reporter expression was markedly lower in GC-Tfh cells than 
the other subsets (Fig. 5A, B), consistent with the very low KLF2 expression by that 
population. CD69 was expressed at significantly higher levels in GC-Tfh than Tfh or 
non-Tfh effector populations (Fig. 5C):  It has been proposed that this phenotype 
indicates TCR stimulation of the GC-Tfh population102, since CD69 is an activation 
marker.  However, CD69 has been shown to compete with S1PR1 for cell surface 
expression, and loss of S1PR1 expression can result in elevated basal CD69 levels20,36,103, 
complicating interpretation of this phenotype. Hence we also monitored evidence for 
recent TCR signaling using the Nur77-GFP reporter transgenic system104. This analysis 
revealed that TCR stimulation was similar in GC-Tfh, Tfh and non-Tfh cells at day 7 of 
the response (Fig. 5D), consistent with the increased CD69 surface expression by GC-Tfh 
at that time being a consequence of lower S1PR1 expression. By day 14 of the response, 
we saw evidence for sustained TCR signaling in the GC-Tfh pool (consistent with the 
conclusions of previous studies)101,102, while Nur77-GFP levels were declining in Tfh and 
non-Tfh phenotype cells.  
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Figure 3-5. Sustained downregulation of KLF2 and S1PR1 expression in GC-Tfh. 
(A, B) Expression levels of KLF2-GFP (top) or S1PR1-GFP (bottom) by TEa CD4+ T 
cells at indicated time points following Eα-SA-DEL/CFA immunization. TEa cells were 
co-transferred with MD4 B cells into WT B6 recipients prior to priming. Data are 
presented as gMFI minus background gMFI of co-transferred non-transgenic TEa CD4+ 
T cells, after gating on the indicated phenotypic subsets (defined in Figure 1). Statistical 
significance was calculated relative to the non-Tfh population. (C) Cell surface 
expression of CD69 on GC-Tfh, Tfh and non-Tfh TEa CD4+ T cells at days 2, 7 and 14 
post Eα-SA-DEL/CFA immunization, presented as gMFI. (D) Expression of Nur77-GFP 
(a reporter for TCR signaling) by GC-Tfh, Tfh and non-Tfh TEa CD4+ T cells (shown as 
gMFI, calculated as above).  Data are from three independent experiments with a total of 
9 recipient mice at each time points. Graphs show accumulated data from the independent 
experiments as mean ±s.d., two-tailed t-test. ns, not significant (P > 0.05); *, P < 0.05; **, 
P < 0.01; and ***, P < 0.001. 
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Loss of KLF2 enhances GC-Tfh generation and the GC B cell response  
While these results indicate that GC-Tfh characteristically display reduced KLF2 
and S1PR1 levels, the functional relevance of this expression pattern was unclear. Hence, 
we examined the consequences of dysregulated KLF2 expression. Analysis of KLF2 
deficient naïve T cells is compromised by their altered trafficking7,95, hence we utilized 
an inducible knockout approach in which tamoxifen administration stimulates ERT2-Cre 
to mediate Klf2 ablation (monitored through a Cre-induced YFP reporter: Fig. 6A, 
B)86,93. Klf2 gene deletion in TEa T CD4+ T cells was initiated at day 2 of the response 
(when KLF2 expression level is already low – Fig. 6A, 5A). Ablation of Klf2 led to a 
striking increase in the frequency (Fig. 6C) and number (data not shown) of GC-Tfh (and 
Tfh) phenotype CD4+ T cells compared to controls, consistent with the hypothesis that 
KLF2 acts to restrain GC-Tfh differentiation.  
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Figure 3-6 Inducible deletion of KLF2 in peripheral CD4+ T cells enhances 
generation of GC-Tfh. (A) Experimental scheme. WT KLF2 TEa cells (KLF2+/+; Cre-
ERT2 / TEa) or KLF2 inducible KO TEa cells (KLF2 fl/fl; KLF2fl/fl / Cre-ERT2 / Rosa-
YFP / TEa) were transferred into WT B6 (with MD4 B cells) or TCRα-/- (without MD4 
B cells) recipients and primed by subcutaneous immunization of Eα-SA-DEL/CFA. 
Tamoxifen was administered via intra-peritoneal injection daily from days 2 to 6 post-
immunization. At day 7 after immunization, pooled spleen and LN cells from each 
recipient were stained with APC conjugated anti-CD45.1 (congenic marker specific for 
transferred TEa CD4+ T cells) antibody, and TEa CD4+ T cells enriched by anti-APC 
magnetic beads pull-down. (b), Representative data on the frequency of YFP induction of 
donor KLF2 inducible KO TEa cells from tamoxifen treated animals at day 7 post 
immunization. (C) Analysis of Tfh differentiation upon tamoxifen-induced (Cre-ERT2) 
KLF2 deletion. Data are from three independent experiments with a total of 9 WT B6 
recipient mice. Graphs show accumulated data from the independent experiments as 
mean ±s.e.m., two-tailed t-test. ***, P < 0.001. 
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To test whether KLF2-deficient CD4+ T cells were functional as GC-Tfh, we 
tested their capacity to mediate antigen specific B cell priming and the GC reaction. Klf2-
inducible knockout TEa T cells were transferred into TCRα-deficient recipients and 
primed with Eα-SA-DEL. In this way, the antigen-specific response of endogenous 
polyclonal B cells can be monitored, while T cell help is limited to the donor population. 
As we observed before, Klf2 deletion in the TCRα-deficient recipients also increased the 
frequency and number of GC-Tfh and Tfh phenotype CD4+ T cells compared to controls 
(Fig. 7A). Serum anti-Eα-SA-DEL IgM, IgG1, IgG2a, IgG2c, IgG3 as well as IgE titers 
were increased within 5 days of induced KLF2-knockout (Fig. 7B). Moreover, inducible 
KLF2 deletion in donor TEa cells increased the number of both plasma cells (Fig. 9A) 
and GC B cells (Fig. 9B) within the Eα-SA specific polyclonal B cell population (Fig. 
8A, B). Taken together, these results showed that deletion of KLF2 in early activated 
CD4+ T cells promoted polarization toward Tfh and GC-Tfh cells, and that those T cell 
populations were functional in providing help for robust antigen specific B cell priming 
and GC dependent isotype switching.  
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Figure 3-7.  Inducible deletion of KLF2 in peripheral CD4+ T cells enhances Tfh 
differentiation and the germinal center B cell response. (A) Absolute numbers of 
donor TEa CD4+ T cells recovered from TCRα KO mice that received KLF2+/+ or 
KLF2 inducible KO TEa cells, determined 7 days after immunization and 5 days after 
tamoxifen treatment. (B) Titers of Eα-SA-DEL specific antibodies in serum from mice 
receiving KLF2+/+ (n=5) or KLF2 fl/fl (n=5) TEa T cells.  Serum samples were collected 
at the day of immunization (pre-immune), beginning of tamoxifen treatment (day 2 after 
immunization:  “D+2”) and 5 days of tamoxifen treatment (day 7 after immunization:  
“D+7”). Graphs show accumulated data from the independent experiments as mean 
±s.e.m., two-tailed t-test. ns, not significant (P > 0.05); *, P < 0.05; **, P < 0.01; and ***, 
P < 0.001. 
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Figure 3-8.  Identification of antigen specific germinal center response. At day 7 after 
immunization, pooled spleen and LN cells from each recipient were stained with Eα-SA-
PE tetramer, and cells enriched by anti-PE magnetic beads pull-down. Host antigen 
specific B cells were identified based on the following criteria: Eα-SA-PE tetramer+ PE-
AF647- Thy1- Gr-1- CD11c- NK1.1- and F4/80-. Plasma blast/cells were determined as 
IC-Ighigh/B220low, and GC B cells were determined as C-Ighigh/B220low/GL7high. 
GC B cells were further validated by surface expression of IgD and IgM. (A) After 
enrichment, B cells were gated as negative for non-B cell lineage markers (“dump”: 
Thy1, Gr-1, CD11c, NK1.1 and F4/80), and the antigen specific B cells were determined 
by PE positive gating (Eα-SA-PE tetramer bound fraction). In order to exclude B cells 
specific for PE (which was not a component of the immunogen) cells were also stained 
with PE-AF647:  Cells stained with Eα-SA-PE but not PE-AF647 were designated as Eα-
SA “antigen” specific. Indeed, plasma cells - B220lo, intracellular immunoglobulin (IC-
Ig)hi - were found in the Eα-SA specific but not PE specific (“Background”) population, 
as expected. (B) Enriched cells were gated as indicated and analyzed for expression of 
CD38, GL7, IgM and IgD.  The designation of the populations as GC B cells or naïve B 
cells is indicated. Data are from three independent experiments with a total of 9 
(KLF2+/+) or 6 (KLF2 fl/fl) TCRα KO recipient mice.  
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Figure 3-9.  Inducible deletion of KLF2 in peripheral CD4+ T cells enhances plasma 
cell and germinal center (GC) B cell differentiaion.   Quantification of endogenous 
Eα-SA specific (A) plasma cells (intracellular immunoglobulin (Ig)high, B220low; left) and 
(B) GC B cells (B220high, GL7high; right). Each symbol represents an individual mouse 
and small horizontal lines indicate the mean. Data are from three independent 
experiments with a total of  9 (KLF2+/+) or 6 (KLF2 fl/fl) TCRα KO recipient mice. 
Graphs show accumulated data from the independent experiments as mean ±s.e.m., two-
tailed t-test. **, P < 0.01. 
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 Forced expression of KLF2 or S1PR1 in CD4+ T cells impairs generation of GC-
Tfh 
As a complementary approach, we next assessed the impact of increased KLF2 
expression on GC Tfh differentiation in vivo, using a retroviral overexpression system20. 
At day 7 p.i., forced expression of KLF2 in TEa CD4+ T cells resulted in a dramatic 
inhibition of Tfh and GC-Tfh cell differentiation (compared to non-transduced and 
“empty” retroviral transduced controls) (Fig. 10), supporting the proposal that KLF2 
played a dominant negative regulatory role in Tfh and GC-Tfh differentiation. KLF2 is 
required for S1PR1 expression in T cells, and previous studies have suggested that 
induction of S1PR1 is sufficient to substitute for KLF2 in control of thymocyte egress105 
and establishment of CD8 T cell resident memory20. Hence, we tested whether the effects 
of forced KLF2 expression were mimicked by S1PR1, using a similar retroviral 
transduction approach. Indeed, ectopic expression of S1PR1, like KLF2, significantly 
decreased generation of Tfh and GC-Tfh CD4+ T cells (Fig. 10). These results suggest 
that downregulation of KLF2 and its target S1PR1 are obligatory steps in the production 
of GC-Tfh CD4+ T cells.  
 
 
   79 
 
Figure 3-10.  Forced expression of KLF2 or S1PR1 inhibits Tfh differentiation. (a) 
TEa CD4+ T cells were in vitro activated and transduced with MiT-based retroviruses 
encoding KLF2, S1Pr1 or no insert (empty) and adoptively transferred (with naïve MD4 
B cells) in recipient mice that were immunized with Eα-SA-DEL in CFA. At day 7 of the 
response, transduced TEa cells (identified by the Thy-1.1 marker) were analyzed for 
phenotypic markers (defined in Figure 1). Data are from at least three independent 
experiments with a total of 11 recipient mice, and graphs show accumulated data from 
the independent experiments as mean ±s.e.m., two-tailed t-test. ***, P < 0.001. 
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KLF2 influences GC-Tfh production independent of S1PR1 regulation 
These findings might suggest that the critical function of KLF2 in controlling Tfh 
production is mediated by control of S1PR1 expression. In order to test this directly, we 
utilized the opportunity to neutralize S1PR1 functional activity with the drug FTY72035. 
As before, S1PR1 overexpression led to reduced generation of Tfh and GC-Tfh, but this 
effect was substantially reversed by treatment with FTY720 (Fig. 11), consistent with the 
hypothesis that S1PR1 expression blocks Tfh and GC-Tfh generation. Surprisingly, 
however, FTY720 treatment had no effect on the skewed Tfh/GC-Tfh differentiation 
induced by forced KLF2 expression (Fig. 11).  This implied that the effects of forced 
KLF2 expression were not limited to induction of S1PR1. Furthermore, FTY720 
treatment did not impact CD4+ T cell differentiation in the control-transduced population 
(Fig. 11), suggesting that S1PR1 function alone was not regulating Tfh/GC-Tfh subset in 
normal cells. Taken together, these studies indicate that S1PR1 expression is a critical 
component, but not the dominant regulatory mechanism though which KLF2 regulates 
GC-Tfh differentiation.  
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Figure 3-11. Effect of FTY720 treatment (S1PR1 blocking) on representation of GC-
Tfh, Tfh and non-Tfh populations within the retrovirally transduced TEa T cells in 
vivo. FTY720 or vehicle control (“Veh.”) was administrated by intra-peritoneal injection 
at day 2, 4, and 6 post immunization, and the phenotype of donor cells were analyzed at 
day 7 after the immunization. Data are from at least three independent experiments with a 
total of 11(a) or 9(b) recipient mice, and graphs show accumulated data from the 
independent experiments as mean ±s.e.m., two-tailed t-test. ***, P < 0.001. 
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KLF2 induces Blimp-1 and affects the balance of Blimp-1/Bcl-6 expression 
Thus, we hypothesized KLF2 would have other downstream targets that affect 
GC-Tfh generation. To address this we tested whether KLF2 regulates expression of 
known factors in the GC-Tfh differentiation pathway. We assessed the impact of KLF2 
overexpression and induced deletion of in vitro stimulated CD4+ T cells, maintained in 
non-polarizing culture conditions (Fig. 12A, B).  
Quantitative RT-PCR data showed KLF2 deletion led to significant induction of 
Bcl6 and reduced expression of the Prdm1 gene (encoding Blimp-1) (Fig. 13A). In 
contrast, over-expression of KLF2 significantly decreased bcl6 gene expression, but 
increased Blimp-1 gene (Fig. 13B) and protein (Fig. 13C). Bcl-6 promotes generation of 
GC-Tfh, while Blimp-1 represses Bcl-6 expression81,88,106, hence these findings reveal 
that KLF2 influences the balance in expression of key transcription factors that regulate 
GC-Tfh differentiation. In contrast, we did not observe effects of KLF2 manipulation on 
mRNA expression of Ascl2, CXCR5, ICOS or IL-21, in these in vitro cultured cells (Fig. 
13A, B and data not shown). Also, forced expression of S1PR1 had no effect on Blimp-1 
or Bcl-6 expression (Fig. 13B, C). Although these data showed that KLF2 impacts the 
balance of Blimp-1 and Bcl-6 expression, the transcriptional antagonism between these 
factors complicates defining how KLF2 regulates this expression profile. 
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Figure 3-12.  In vitro cell culture conditions and resulting KLF2-GFP expression 
pattern. For in vitro culture studies, isolated KLF2-GFP CD4+ T cells were initially 
primed with IL-2 (20ng/ml) for 24 hours and further cultured with IL-15 (20ng/ml) for 48 
hours in anti-CD3/CD28 coated plates. Cells were then transferred to non-coated plates 
and cultured to recover KLF2-GFP expression for an additional 48 hours. The timing for 
retroviral transduction and 4-OH tamoxifen (100nM) treatment (for KLF2fl/fl inducible 
knockout) is indicated. Graph (A) and FACS plots (B) show expression of KLF2-GFP in 
KLF2GFP reporter TEa CD4+ T cells (blue) during in vitro culture, presented as 
experimental gMFI minus background gMFI of co-cultured non-transgenic TEa CD4+ T 
cells (red). This in vitro culture experiment was repeated three times with similar results. 
All data are representative of at least three independent experiments. Graphs show 
accumulated data from the independent experiments as mean ±s.e.m..
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Figure 3-13.  Transcriptional regulation of KLF2 in expression of CD4+ T cell 
lineage defining factors. (A, B) RT-PCR analysis of various genes (horizontal axis) for 
in vitro cultured KLF2 KO (A) or retrovirus-transduced (B) TEa CD4+ T cells after 
sorting based on expression of Cre-reporter signal (for KLF2 KO; YFP+) or retro-
transduction marker (Thy1.1). (Detailed in vitro culture conditions are described in Fig. 
12). (C) FACS analysis of transcription factor expression in retrovirally-transduced TEa 
cells (identified by Thy1.1+ expression). Induction of Blimp-1 in the retrovirus-infected 
Blimp-1-YFP reporter CD4+ T cells in vitro. All experiments repeated at least three times 
with similar results. Graphs show accumulated data from the independent experiments as 
mean ±s.e.m., two-tailed t-test. **, P < 0.01; and ***, P < 0.001. 
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To test whether KLF2 directly binds to promoters for these genes, we performed 
chromatin immunoprecipitation (ChIP) assays for KLF2-GFP on both naïve and activated 
CD4 T cells. As expected, KLF2 was found at the promoter of S1pr1 in naïve and 
activated CD4+ T cells (Fig. 14). In addition, we found that KLF2 bound the promoter 
region of the gene encoding Blimp-1 (Prdm1) following T cell activation, but we did not 
observe a significant ChIP signal for KLF2 at the Bcl6 promoter (Fig. 14).  These 
findings are consistent with changes in Bcl6 mRNA expression (Fig. 13A, B) being 
secondary to KLF2 induction of the repressor Blimp-1.  
 
Figure 3-14.  KLF2 chromatin immunoprecipitation (ChIP). ChIP analysis of naïve 
or in vitro activated KLF2GFP-reporter TEa CD4+ T cells, followed by chromatin 
immunoprecipitation using rabbit IgG (control) or anti-GFP and quantitative PCR 
analysis of binding at the promotor regions of each gene (horizontal axis) (primers are 
listed in Materials and Methods). Results were normalized to those of a standardized 
aliquot of input chromatin, followed by subtraction of the signal obtained with IgG 
(nonspecific background). All experiments repeated at least three times with similar 
results. Graphs show accumulated data from the independent experiments as mean 
±s.e.m., two-tailed t-test. ns, not significant (P > 0.05); *, P < 0.05; and ***, P < 0.001. 
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KLF2 promotes expression of T-bet and Gata3 and Th1 generation  
To broaden our analysis, we also explored how expression of transcription factors 
that define other T helper (Th) subsets is affected by KLF2 manipulation. Intriguingly, 
over-expression of KLF2 also led to substantially increased expression of T-Bet (Tbx21) 
and Gata3 genes and proteins, but did not affect expression of the genes for Rorγt (Rorc) 
or Foxp3 (Fig. 13B, 15A and data not shown). Furthermore, ChIP assays revealed that 
KLF2 occupies the regulatory regions of the genes for T-Bet (Tbx21) and GATA3 
(Gata3) following T cell activation (Fig. 14). It is important to note, however, that 
induced KLF2 deficiency did not lead to reduced expression of Tbx21 or Gata3, in 
contrast with the decline in Prdm1 expression, suggesting KLF2 is not required for Tbx21 
or Gata3 expression (Fig. 13A). Nevertheless, enforced KLF2 expression led to a 
significant increase in the frequency of CD4 T cells with the canonical Th1 function of 
IFN-γ production (Fig. 15B, C), in keeping with strong enhancement of T-bet expression. 
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Figure 3-15.  KLF2 promotes T-Bet and GATA3 expression in activated CD4+ T 
cells and dictates Th1 lineage differentiation. (A) T-Bet and GATA3 expression in the 
retrovirus-infected TEa CD4+ T cells in vitro. (B, C) Percentage of IFN-γ producing 
population upon PMA/Ionomycin stimulation for 3 hours in the retrovirus-infected TEa 
CD4+ T cells in vitro. All experiments repeated at least three times with similar results. 
Graphs show accumulated data from the independent experiments as mean ±s.e.m., two-
tailed t-test. **, P < 0.01; and ***, P < 0.001. 
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We next extended these studies to explore how KLF2 expression influenced Th 
subset-defining transcription factor expression in vivo. To assess this, we analyzed 
expression of key transcription factors in responding CD4 T (using a sequential gating 
strategy - Fig. 16A). Consistent with the studies discussed above, forced expression of 
either KLF2 or S1PR1 led to a decrease in the frequency of CD4 T cells that 
predominantly expressed Bcl-6, while ectopic KLF2 (but not S1PR1) led to a substantial 
increase in frequencies of cells expressing T-bet and a proportional decrease in the 
fraction of cells expressing RORγt (Fig. 16B, C). Forced KLF2 expression induced a 
modest (although significant) increase in the frequency of T-bet-/Gata3+ cells (Fig. 16B, 
C). Unexpectedly, we found that the increased frequency of T-bet+ cells induced by 
KLF2 transduction was predominantly a population that co-expressed both Gata3 and T-
Bet (Fig. 16C, D). 
KLF2 over-expression might induce non-physiological gene expression patterns.  
Hence we also evaluated whether endogenous KLF2 expression levels correlated with 
expression of lineage-defining transcription factors in differentiating TEa CD4+ T cells. 
KLF2 levels were lowest in the Bcl-6hi pool, corresponding to GC-Tfh (Fig. 17A, B).  
On the other hand, TEa CD4+ T cells co-expressing T-Bet and GATA3 were 
characterized by substantially higher expression levels of endogenous KLF2 (Fig. 17A, 
B). Other transcription-factor defined subsets showed intermediate levels of endogenous 
KLF2 (Fig. 17B). These data support the hypothesis that physiological KLF2 expression 
levels correspond with expression of the Th lineage-defining transcription factors that are 
direct targets of KLF2. 
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Figure 3-16.  KLF2 induces T-bet and GATA3 expression during CD4 T cell lineage 
commitment in vivo. Analysis of in vivo derived Th subsets. (A) The gating strategy of 
CD4+ helper T cell lineages. At day 7 after subcutaneous immunization of Eα-SA-
DEL/CFA, donor CD4+ TEa cells were enriched and analyzed for lineage specific 
transcription factor expression. First, the Treg population was identified by FoxP3 and 
CD25 expression. FoxP3- (non-Treg) cells were characterized for RORγT+ expression 
(identifying presumed Th17 cells).  Next, the RORγT- population was further sub-
populated into T-bet+ and GATA3+/T-bet- populations.  Finally, the Bcl6+/CD25- Tfh 
cells were identified within the T-betlow/GATA3- population. (B) Analysis of TEa 
CD4+ T cells for expression of lineage-defining transcription factors following 
transduction with indicated retroviruses at day 7 post immunization in vivo. (C, B) 
Analysis of T-bet and GATA3 double positive TEa CD4+ T cells in T-bet+ population 
(Th1; T-bet+FoxP3-RORγT-). Data are from at least three independent experiments with 
a total of 15, and graphs show accumulated data from the independent experiments as 
mean ±s.e.m., two-tailed t-test. ns, not significant (P > 0.05); *, P < 0.05; and ***, P < 
0.001. 
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Figure 3-17.  KLF2 expression is corelated with T-Bet/GATA3 and inversly 
corelated with Bcl6 in effector CD4+ T cells in vivo.  (A, B) KLF2-GFP expression 
level (gMFI) within TEa CD4+ T cells expressing the indicated transcription factors at 
day 7 post immunization. Data are from at least three independent experiments with a 
total of  9 KLF2-GFP reporter mice, and graphs show accumulated data from the 
independent experiments as mean ±s.e.m., two-tailed t-test. ***, P < 0.001. 
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Discussion 
 The factors that determine both Tfh differentiation and localization within the 
germinal center are still being defined. In particular, whether and how those features are 
coordinately regulated by individual factors is unclear. In this report, we show that one 
transcription factor, KLF2, influences both activated CD4+ T cell trafficking (through 
regulation of S1PR1) and Th subset differentiation (through control of Blimp-1, T-bet 
and Gata3), such that KLF2 expression directs differentiating CD4+ T cells away from 
the Tfh fate. However, KLF2 does not simply act as a block for Tfh differentiation: 
rather, the regulation of multiple key transcription factors suggests KLF2 serves to shape 
alternative Th differentiation choices. Indeed, we find that the physiological KLF2 
expression levels correlate with expression of lineage-defining transcription factors, 
suggesting that KLF2 levels can serve to tune the Th-subset differentiation fate.  
We and others reported that KLF2 regulates expression of the S1PR1, which is 
critical for lymphocyte recirculation7,20,34,95. Indeed, for certain functions – such as the 
substituted by expression of S1PR134,105. Furthermore, in recent studies we showed that 
ectopic expression of either KLF2 or S1PR1 was sufficient to impede establishment of 
resident memory CD8+ T cells20. Similarly we found that forced expression of S1PR1 in 
activated CD4+ T cells led to a dramatic reduction in generation of Tfh. This effect 
correlated with functional activity and/or expression of S1PR1 on the cell surface, since 
treatment with FTY720 substantially reversed the effects of S1PR1 overexpression. One 
interpretation of these findings is that S1PR1 expression opposes the migration of 
activated T cells into the follicle, thereby blunting the reinforcing signals that normally 
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drive continued Tfh differentiation as CD4+ T cells migrate into the B cell follicle. 
S1PR1 signals over-ride migration induced by CXCR5 in MZ B cells107, and counteract 
responses through a related chemokine receptor CCR7 in T cells35,36. In addition, S1PR2 
has recently been shown to cooperate with CXCR5 for efficient GC-Tfh generation84 – 
since S1PR1 and S1PR2 signal through distinct G-protein complexes, they can have 
opposing effects on cell migration35. Encounter with B cells and continued antigen 
stimulation is needed for sustained expression of Bcl-6 and expansion of the Tfh 
population81,101 - hence denying activated CD4+ T cells access to the B cell follicle could 
explain the deficit in CXCR5-expressing cells following forced S1PR1 expression.  
Nevertheless, our data indicate that S1PR1 regulation is not sufficient to explain 
the effects of KLF2 expression on Tfh differentiation. FTY720 treatment did not reverse 
the paucity in Tfh and GC-Tfh generation that followed transduction with a KLF2-
encoding retrovirus. This suggested that blocking the S1PR1-mediated changes in cell 
trafficking was insufficient to compensate for dysregulated KLF2 expression. It is 
unlikely that this difference is a consequence of the dose of FTY720 being too low to 
affect the KLF2 transduced cells, since mRNA expression for S1PR1 was lower in KLF2 
transduced compared to S1PR1 transduced CD4+ T cells (Fig. 13b). It is also noteworthy 
that FTY720 treatment did not impact the ratios of non-Tfh, Tfh and GC-Tfh for control 
TEa cells – this implies that there is not a cohort of normal activated CD4+ T cells that 
are prevented from Tfh differentiation due to expression of S1PR1 alone. So, while 
S1PR1 downregulation is clearly necessary for effective Tfh generation and/or 
maintenance, this does not fully account for the significance of KLF2 downregulation.  
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Our further studies showed that KLF2 had an unexpected impact on a series of T 
cell lineage-defining transcription factors. Overexpression of KLF2 led to increased 
expression of Blimp-1, while induced ablation of the klf2 gene led to the opposite 
outcome. Bcl-6 expression changed in the reciprocal direction, as expected from the 
known mutual repression exerted between Bcl-6 and Blimp-181,88,106. Given this 
expression pattern, KLF2 could potentially regulate either (or both) Bcl-6 and Blimp-1, 
however, our data from ChIP suggested that Blimp-1 was a direct target for KLF2 
binding. Previous studies on CD8+ T cells showed that forced KLF2 led to elevated 
Blimp-1 expression38,39, consistent with this result – but the impact on Bcl-6 expression, 
and impact of KLF2 deletion on Blimp-1/Bcl-6 expression has not been reported. We did 
not note gene expression changes in Ascl-2, CXCR5, ICOS or IL-21 when KLF2 levels 
were manipulated, but it is possible that our in vitro studies would not reveal those 
changes, and further analysis of KLF2 binding to other genes involved in Tfh 
differentiation and migration will be important. Nevertheless, our data on the impact of 
KLF2 on the balance between Blimp-1 and Bcl-6 expression levels provides a ready 
explanation for KLF2’s ability to derail the Tfh differentiation pathway.  
Surprisingly, we also observed that elevated KLF2 expression could induce the T-
bet and Gata3 transcription factors, and ChIP assays suggested KLF2 directly bound to 
the regulatory regions for the genes encoding these factors. Our data suggest this 
regulation is not simply an artifact of overexpression studies, since analysis of normal 
TEa cells responding in vivo showed that the populations expressing T-bet and Gata3 had 
significantly higher levels of endogenous KLF2. T-bet and Gata3 are frequently co-
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expressed in human Th1 cells108, but analysis in mouse T cells suggest these two factors 
are normally differentially expressed (with Th1 cells expressing T-bet and Th2 cells 
expressing Gata3)109. While there have been studies suggesting that restimulating Th1 
cells in Th2 conditions can provoke T-bet+/Gata3+ cells with hybrid Th1/Th2 
properties110, our studies found that KLF2 overexpressing CD4 T cells are potentiated for 
production of the Th1 cytokine IFN-γ, but did not exhibit detectable production of the 
Th2 cytokine IL-4. Studies comparing the gene expression characteristics of T-bet/Gata3 
co-expressing cells suggest that T-bet typically co-opts Gata3 to support induction of 
genes characteristic of the Th1 lineage111, in keeping with our findings. Others have 
reported that Blimp-1 acts to directly repress expression of T-bet and IFN-γ in activated 
CD4+ T cells112, while our studies indicate that, when induced by KLF2, Blimp-1 and T-
bet can be co-expressed. Though the significance of KLF2hi cells expressing T-bet and 
Gata3 will require further study, these findings suggest that KLF2 expression does not 
simply present a barrier to Tfh differentiation, but can foster the differentiation into other 
Th lineages (Th1 and potentially Th2). Hence these data suggest KLF2 acts as a critical 
pivot in regulating which Th subset developmental pathway a CD4 T cell will follow.  
 Kruppel-like factors play diverse roles in multiple tissues, often related to late 
differentiation steps8,20. We and others showed that KLF2 regulates B cell subset 
differentiation8,113. The studies reported here demonstrate a novel and significant impact 
of KLF2 expression on helper CD4 T cell subset differentiation in two separable ways:  
Through trafficking (via S1PR1) and through regulation of three lineage-defining 
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transcription factors (Blimp-1, T-bet and GATA3). Hence KLF2 serves a hitherto 
unsuspected function in dictating the lineage fate of CD4 T cells. 
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Materials and methods 
Mice 
C57BL/6 (B6) and B6.SJL mice were purchased from the National Cancer 
Institute, and ETR2-Cre, Blimp1-YFP and Tcra−/− mice were obtained from Jackson 
Laboratories. TEa TCR transgenic mice (specific for a peptide from the I-Eα MHC II 
molecule (pEα) bound to I-Ab), and MD4 BCR transgenic mice (specific for hen/duck 
egg lysozyme (HEL/DEL)) were maintained at the University of Minnesota. The S1PR1 
reporter strain was a kind gift of Dr. Hugh Rosen (Research Institute of the Scripps 
Clinic) – this and the KLF2-GFP, Nur77-GFP and KLF2 fl/fl mice have been previously 
described20,97,100,104,114 and were crossed to TEa mice at the University of Minnesota. 
KLF2fl/fl/TEa mice were further bred with ETR2-Cre and Rosa26-YFP mice to generate 
KLF2fl/fl/ETR2-Cre/Rosa26-YFP/TEa (KLF2 fl/fl) and KLF2+/+/ETR2-Cre/TEa (KLF2 
+/+) control mice. For adoptive co-transfer studies, combinations of CD45.2+, CD45.1+ 
and CD45.1+CD45.2+ mice were used as donor and host strains to allow discrimination 
between each donor population and the host cells. Six to eight week old mice were used 
for all experiments. Animals were maintained under specific pathogen free conditions at 
the University of Minnesota. All experimental procedures were approved by the 
Institutional Animal Care and Use Committee at the University of Minnesota. 
 
Infections and MHC II-tetramer based cell enrichment 
Mice were injected intravenously with 1×107 colony-forming units of ActA-
deficient LM-2W1S bacteria or intraperitoneally (i.p.) with 2×105 plaque-forming units 
   98 
of the LCMV Armstrong strain. Tetramers composed of I-Ab and either 2W1S, LLO190-
201, or LCMV glycoprotein (GP) 66-77 peptides were made as described 
previously101,115. Single cell suspensions of spleen and LN cells were stained for 1 hour at 
room temperature with the PE or APC-conjugated tetramers and 2 µg of CXCR5-BV421 
antibody (2G8; BD bioscience). Samples were then enriched and enumerated as 
described previously101,115. For identification of surface markers, the sample was stained 
on ice with antibodies specific for MHCII (M5/114.15.2), F4/80 (BM8), B220 (RA3-
6B2), CD11c (N418), CD8α (53-6.7), PD-1 (J43), CD4+ (RM4-5), CD3ε (145-2C11), 
CD44 (IM7), CD45.1 (A20), CD45.2 (104) and CD69 (H1.2F3). Intracellular staining for 
T-bet (4B10, BioLegend), GATA3 (TWAJ), RORγT (Q31-378, BD bioscience), FoxP3 
(FJK-16s) and Bcl-6 (K112-91, BD bioscience) was performed as described 
previously101,116. For determining reporter signal in CD4+ T cell lineage subpopulations, 
intracellular staining for anti-GFP antibody (rabbit, Life technologies) followed by 
AlexaFluor488 goat anti-rabbit IgG antibody (Life technologies) was performed. All 
antibodies were from eBioscience (San Diego) unless otherwise noted. Cells were then 
analyzed on an LSR II or Fortessa (Becton Dickinson) flow cytometer. Data were 
analyzed with FlowJo (TreeStar). 
 
Adoptive transfer and Eα-SA-DEL immunization 
For adoptive transfer experiments, 1x105 TEa CD4+ T cells were typically co-
transferred with 5x104 MD4 B cells into WT B6, B6.SJL, or Tcra−/− mice depending on 
the CD45 congenic marker expression of the donor cells. Naive CD4+ T cells from 
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various TEa strains mice were isolated by using mouse CD4+ T Cell Isolation Kit 
(Miltenyi Biotec), and MD4 B cells were isolated by using mouse B Cell Isolation Kit 
(Miltenyi Biotec). For reporter studies, background reporter signal was evaluated by 
mixing reporter and congenic WT TEa CD4+ T-cells at a ratio of 1:1, and 5×104 of each 
TEa CD4+ T cells were transferred into congenic recipient mice. After 12 hours, the 
recipients were immunized subcutaneously (7µM in 50  µl per mouse) with a conjugate 
antigen bearing antigens for both TEa and MD4 cells (Eα-SA-DEL) emulsified in CFA 
(0.5  mg/  ml). On the day of harvest, TEa CD4+ T cells were enriched based on CD45 
expression as described previously20. 
To generate the conjugated antigen (Eα-SA-DEL), biotinylated Eα peptide (Eα-
Bio) and Streptavidin (SA) were purchased from New England Peptide and ProZyme 
respectively. Purified duck egg lysozyme (DEL) was obtained by special order from 
Worthington Biochemical Corporation, and biotinylated using an EZ-link Sulfo-NHS-LC 
Biotinylation kit (Thermo Fisher Scientific) using a 1:1 ratio of biotin to protein. After 
removal of free biotin by use of desalting columns (GE Healthcare), the molar amount of 
biotinylated DEL (DEL-Bio) was measured by Western blot, as previously described117. 
The prepared Eα-Bio and DEL-Bio were then conjugated by incubation with SA (Eα-
Bio:DEL-Bio:SA= 2:2:1 ratio) at room temperature for 30 minutes.  
  
Inducible KLF2 deletion and B cell germinal center reaction  
In vivo KLF2 deletion of KLF2 fl/fl (KLF2fl/fl/ETR2-Cre/Rosa26-YFP/TEa) 
cells in WT B6.SJL or Tcra-/- recipient mice was achieved by administering tamoxifen 
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(10  mg/ml) in sunflower seed oil i.p. for 5 consecutive days from day 2 post- 
immunization. At day 7 post-immunization, the spleen and inguinal, axillary, brachial, 
cervical and mesenteric LNs were harvested and analyzed. KLF2 fl/fl or KLF2 +/+ 
control cells were enriched through their congenic markers, and KLF2 KO populations 
were identified by YFP expression (Rosa26-YFP reporter). For in vitro KLF2 deletion, 
primed KLF2 fl/fl cells (cultured with recombinant IL-2 (20ng/ml), anti-CD3 (8 µg/ml 
per well; 145-2C11; BioXCell), and anti-CD28 (8 µg/ml per well; 37.51; BioXCell) 
coated plate for 24 hours) were cultured with 4-OH tamoxifen (100nM) and IL-15 
(20ng/ml) for 48 hours in anti-CD3/CD28 coated wells, followed by 48 hours of 
additional culture in IL-15 in non-coated plates. 
Antigen specific B cells were identified and enriched using Eα-SA-PE tetramer. 
Eα-SA-PE tetramer was prepared by incubation of Eα-Bio and SA-PE (4:1 ratio) at room 
temperature for 30 minutes. Antigen specific endogenous B cells from pooled spleen and 
LNs of the Tcra-/- recipients were stained with Eα-SA-PE tetramer, and enriched by anti-
PE magnetic beads pull-down118.  Sera from immunized mice were collected at day 0, 2 
and 7 post immunization, and antigen-specific IgM, IgG1, IgG2a, IgG2b, IgG2c, IgG3, 
IgA and IgE antibodies were measured by ELISA as previously described10. Briefly, sera 
were titrated into ELISA plates that had been coated with Eα-SA-DEL (20µg/ml in PBS, 
overnight) then blocked with 1% BSA. HRP conjugated anti-mouse-antibody isotype 
antibodies (Southern Biotech) were applied and detected using ABTS Peroxidase 
Substrate (KPL). Titers were presented as the maximum serum dilution exceeding 1.5-
fold above the average background.  
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Retroviral transduction approaches  
All retrovirus constructs (Empty control, KLF2 and S1PR1) were cloned using 
MSCV-IRES-Thy1.1 (MiT) backbone vector as described previously20. The plasmid 
MiT-S1PR1, MiT-KLF2 or MiT (empty vector) was transfected together with the 
retroviral packaging vector pCL-Eco into 293T human embryonic kidney cells with 
Lipofectamine 2000 (Life Technology). Supernatants were collected at 48 h after 
transfection.  
Naive CD4+ T cells from TEa or Blimp1-YFP mice were isolated and activated 
by plate-bound anti-CD3 and anti-CD28 with recombinant IL-2 (20ng/ml). 24 hours after 
activation, cells were spin-infected by retroviruses MiT-KLF2, MiT-S1PR1 or control 
empty vector (MiT-Empty) as described previously20. Some transduced cells were 
transferred with MD4 B cells into congenic recipients that were then immunized with Eα-
SA-DEL/CFA. In some experiment, S1PR1 function was inhibited by i.p. injection 
(200ml) of FTY720 (20µg/mouse) or vehicle control (10% EtOH in PBS) at day 2, 4 and 
6 post immunization. For in vitro over-expression of KLF2 or S1PR1, the retrovirally 
transduced CD4+ T cells were cultured with recombinant IL-15 (20ng/ml) in anti-
CD3/CD28 coated plate for 2 days, and were further cultured with recombinant IL-15 
(20ng/ml) in non-coated plate. To examine cytokine production in the KLF2 or S1PR1 
over-expressing TEa cells, cells were re-stimulated with PMA (50ng/ml, SIGMA) and 
ionomycin (1.5µM, SIGMA) in the presence of Monensin for 5  h and intracellular 
staining for IFN-γ (XMG1.2), IL-4 (11B11) and IL-17 (eBio17B7) was performed. 
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Chromatin immuneprecipitation (ChIP) 
ChIP was performed as previously described119. Briefly, approximately 107 naïve 
or in vitro activated KLF2-GFP TEa cells were cross-linked with 1% formaldehyde at 
room temperature for 10 min and neutralized with 0.125  M glycine for 10 minutes. 
Chromatin was fragmented using Bioruptor®. Subsequently, the soluble chromatin was 
incubated with 5 µg of anti-GFP (Life technologies) or control rabbit IgG antibodies at 
4°C overnight. Immunoprecipitated complexes were collected using 30ul Dynabeads G 
(Invitrogen) per reaction. Final ChIP DNA was extracted and purified using QIAquick 
spin columns (Qiagen). Precipitated DNA and input DNA were assessed by quantitative 
real-time PCR with SYBR Green PCR Master Mix (Applied Biosystems). The sequences 
of the primer pairs used were as follows: for the prdm1 promoter region, forward, 5’-
TTTTGTTGTCCCTGCCTCTC-3’, and reverse, 5’-CCCCTTTTTAACTGGGAAGC-3’; 
for the s1pr1 promoter region, forward, 5’-ACCAGCTCACTCGCAAAGTT-3’, and 
reverse, 5’-GCGCTCAGAGACTTCGTCTT-3’; for the bcl6 promoter region, forward, 
5’-GGCAGCAACAGCAATAATCA-3’, and reverse, 5’-
CGAGAATTGAGCTCTGTTGA-3’; for the tbx21 promoter region, forward, 5’- 
CGTCCGAAGACCAATGAAAC-3’, and reverse, 5’-
TCATAAAGCCACAGCAAAGG-3’; and for the gata3 promoter region, forward, 5’- 
GGGTTTGGGTTGCAGTTTCCTTGT-3’, and reverse, 5’- 
GCGACGCAACTTAAGGAGGTTCTA-3’. 
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Quantitative RT-PCR 
After in vitro deletion of KLF2 or retroviral overexpression of KLF2 (S1PR1), 
cells were sorted on a FACSAria (Becton Dickinson) on the basis of the YFP (Rosa26-
YFP Cre reporter) or Thy1.1 transduction markers respectively. In all cases, RNA was 
isolated with an RNeasy microkit (Qiagen), followed by reverse transcription 
(SuperScript® III Reverse Transcriptase, Life technologies). Gene expression was 
assessed (in triplicate for cultured cells) with an ABI 7700 sequence-detection system, 
and amplification was detected with SYBR Green PCR Master Mix (Applied 
Biosystems). 
Cycling threshold values for the control target gene (Gapdh) were subtracted from 
cycle threshold values for the gene of interest. Next, the mean values (averaged across all 
repeated experiments) for gene expression of WT (KLF2 +/+) or non-overexpressing 
control (Empty) TEa cells were used for normalization between experiments. The 
sequences of the primer pairs used were as follows: klf2, forward, 5’- 
ACCAACTGCGGCAAGACCTA-3’, and reverse, 5’- 
CATCCTTCCCAGTTGCAATGA-3’; s1pr1, forward, 5’-
GTGTAGACCCAGAGTCCTGCG-3’, and reverse, 5’-
AGCTTTTCCTTGGCTGGAGAG-3’; prdm1, forward, 5’- 
GACGGGGGTACTTCTGTTCA-3’, and reverse, 5’- GGCATTCTTGGGAACTGTGT-
3’; bcl6, forward, 5’- CACACCCGTCCATCATTGAA-3’, and reverse, 5’- 
TGTCCTCACGGTGCCTTTTT-3’; tbx21, forward, 5’- 
CAACAACCCCTTTGCCAAAG-3’, and reverse, 5’- TCCCCCAAGCAGTTGACAGT-
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3’; gata3, forward, 5’- AGAACCGGCCCCTTATGAA-3’, and reverse, 5’- 
AGTTCGCGCAGGATGTCC-3’; rorc, forward, 5’-GGAGGTGACCAGCTACCAGA-
3’, and reverse, 5’-TGGCAAACTCCACCACATAC-3’; foxp3, forward, 5’-
GGCCCTTCTCCAGGACAGA-3’, and reverse, 5’-GCTGATCATGGCTGGGTTGT-3’; 
ascl2, forward, 5’- CGCTGCCCAGACTCATGCCC-3’, and reverse, 5’- 
GCTTTACGCGGTTGCGCTCG-3’; CXCR5, forward, 5’- 
ACTCCTTACCACAGTGCACCTT-3’, and reverse, 5’- 
GGAAACGGGAGGTGAACCA-3’; GAPDH, forward, 5’- 
TGGCCTACATGGCCTCCA -3’, and reverse, 5’- TCCCTAGGCCCCTCCTGTTAT-3’; 
 
Immunohistochemistry 
KLF2-GFP or WT B6 mice were subcutaneously immunized with PE (15µg in 
CFA) at the base of the tail and were sacrificed after 14 days. Draining LNs were fixed 
with 4% PFA and incubated in 30% sucrose solution.  Five micrometer sections were cut 
and stained with anti-GFP antibody (Life technology). GFP fluorescence intensities were 
quantified in GC (GL7 and B220 abundant) or T cell zone (CD4+ abundant and B220 
negative) CD4+ T cells using ImageJ software according to histocytometric algorithms as 
previously described120. 
 
Statistical analysis 
Data were analyzed with Prism software 4.0 (GraphPad). For standard data sets, 
an unpaired two-tailed Student's t-test was used. For values that differed by over tenfold, 
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the data was log10-transformed before t-test analysis. When data were normalized (by the 
appropriate control samples), normalization involved division of all values by the overall 
mean of the control values to avoid type I and II errors during calculation of significance 
through the t-test. Data sets (in Prism format) are available on request.   
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Immunological function of Virtual Memory CD8 T cells 
                   
 
In Chapter 2, our studies show naturally occurring VM cells constitute a bridge 
between the response of naïve and antigen-experienced memory CD8 T cells.  
Specifically, my initial work focused on characterizing functional properties of VM CD8 
T cells. Previous studies suggested that antigen-driven TM CD8 T cells display changes 
in gene expression, cytokine production, and cell cycle regulation, all of which are 
thought to enhance the capacity of these cells to rapidly enter an immune response23,53,55-
58,63,121. Hence we investigated whether VM share these features with TM, and found that 
the VM population resembled TM cells in their expression of the T-box transcription 
factors T-bet and Eomes, which serve as critical regulators of effector functions and 
differentiation of memory CD8 T cells. Also, VM populations were significantly 
enriched in cells at G1 phase and showed rapid expansion following in vivo priming, 
compared with the naïve pool. However, unlike TM CD8 T cells, the VM pool exhibited 
impaired capacity for rapid IFN-γ synthesis and preferentially differentiated into central 
memory population after in vivo priming. Importantly, although VM and TM displayed 
several differences in functional properties, VM resembled TM cells in their efficient 
control of Listeria monocytogenes infection, indicating that VM cells can contribute to 
rapid pathogen elimination during a primary immune response. Although the VM pool 
accounts for only a fraction (~10%) of antigen-specific precursors for a given foreign 
antigen, this may constitute a significant pool in the response to a complex pathogen.  For 
example, elegant in vivo limiting dilution assays estimate that ~14,000 CD8 T cells (in an 
   108 
unprimed C57BL/6 mouse) are responsive to vaccinia virus122:  this would correspond, 
on average, to > 1000 vaccinia specific VM cells.  Since we observed protective 
immunity against LM-OVA after adoptive transfer of a few thousand Ova/Kb specific 
cells (Fig .14), these calculations suggest that the naturally arising VM pool may serve a 
hitherto unappreciated role in “pre-immune” resistance to infection, at least in mice. 
Currently, to further extend my initial study, I am investigating the immune-
regulatory role of VM CD8 T cells during lung infection with influenza virus. Previous 
studies have connected the superior memory response of CD8 T cells with collateral lung 
damage and increased immunopathology during influenza virus infection123-125. However, 
interestingly, our recent data showed that the VM CD8 T cells preferentially produce the 
immunosuppressive cytokine IL-10 in the infected lung and preserve the tissue function 
in the IL-10 dependent manner. Importantly, VM CD8 T cells still displayed similar virus 
clearance ability compared to TM population (not included in this dissertation). These 
finding indicate that VM cells have additional unique functional properties that allow 
them to balance between effective immune response and immunopathology during 
primary pathogen encounter. 
 
“Are VM cells present in human? If they are, do they provide similar pre-immune 
protection? Do they modulate immune balance during acute local infection in human, like 
in mice?” Our research in the mouse system raises the significance of these questions. 
Recently, studies on human T cells have shown that significant fraction of CD4 T cells 
specific for unexperienced foreign antigens (such as HIV specific CD4 T cells in sero-
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negative individual) shows memory-like phenotype126. Although the authors of that study 
proposed that these memory-like CD4+ T cells were generated through cross-reaction 
with environmental microbes, these data are also compatible with the idea that the human 
immune system generates a VM population in the absence of foreign antigen exposure. 
However, because of the genetic heterogeneity and multiple pathogen exposers during 
lifetime, defining the origins of these memory populations in human is very difficult. 
Therefore, to further study the immune function of homeostatic-memory T cells in 
humans, genetic and epigenetic unique features of the population that separate them from 
antigen-exposed memory T cells should be identified. 
 
Role of KLF2 in effector CD4+ T cell lineage commitment 
 
In the second project, I studied the transcriptional regulation of KLF2 and its role 
in the cell fate determination of effector and memory T cells. My initial collaborative 
work with former graduate student of our lab, Dr. Cara Skon, focused on CD8 T cells 
showed that KLF2 and its transcriptional target S1PR1 provide a molecular switch 
determining whether CD8 T cells commit to recirculating or tissue-resident memory 
(Trm) populations (not included in this dissertation)20. The data suggest that induced 
down-regulation of KLF2 or S1PR1 could be used as a method to enhance the formation 
of Trm during vaccination.  Trm may also contribute to pathological conditions, such as 
fixed drug eruptions in the skin.  Hence, our studies indicate potential therapeutic targets 
through which generation of resident memory CD8 T cells can be promoted or reversed.  
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Next, to extend our finding in CD8 T cells, I investigated whether CD4 T cells 
also have heterogeneity in terms of KLF2 and its target gene expression during antigen-
specific immune response. I observed that KLF2 levels are drastically reduced on 
follicular helper CD4 T cells (Tfh) compared to non-Tfh populations of CD4 T cells. My 
data show that, similar to our findings with resident memory CD8 T cells, loss of the 
KLF2 target S1PR1 is critical for establishment of Tfh. S1PR1 serves to oppose 
migration induced by Gαi-chemokine receptor such as CCR736,85, during regulation of T 
cell recirculation through lymphoid tissues, and it is possible that S1PR1 expression also 
impairs activated CD4 T cell entry into the B cell follicle.  However, I also find that 
KLF2 plays an additional role in regulating the balance of Blimp-1 and Bcl-6 expression 
during activated CD4 T cell differentiation, providing a second mechanism through 
which KLF2 controls the Tfh cell fate. These data suggest that KLF2 has crucial roles not 
only in proper cellular positioning (by regulating expression of S1PR1 and, incidentally, 
CD62L), but also in regulating lineage commitment of primed T cells during peripheral 
immune response. Surprisingly and unexpectedly, I also found that KLF2 promote T-bet 
and GATA3 expression, critical regulator for Th1 and Th2 differentiation 
respectively15,16, suggesting that KLF2 may serve a hitherto unsuspected function in 
dictating the lineage fate of CD4 T-cells. 
The factors regulating KLF2 expression during Th subset differentiation are 
currently unclear. KLF2 expression is downregulated with TCR activation, and it is 
notable that, through analysis of the Nur77-GFP mice, I find evidence that TCR 
engagement is sustained in cells of GC-Tfh phenotype, while this signal declines in non-
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Tfh cells. This correlates with data indicating that TCR engagement is required for 
sustaining Tfh proliferation and maintenance127. However, this finding does not exclude 
the potential action of other factors. Signals that provoke strong PI3K/Akt activation can 
lead to loss of KLF2 expression20, at least in part due to degradation of the transcription 
factor Foxo1 (which promotes KLF2 expression)20,91,128-130. Foxo1 ablation leads to 
substantially enhanced Tfh differentiation91,92, and recent studies indicate that 
degradation of Foxo1 through action of the E3 ubiquitin ligase Itch was important for Tfh 
differentiation, and that Itch deficiency led to elevated expression of Foxo1 target genes 
(including KLF2)92,95,130. Studies with CD8+ T cells have shown that various cytokines - 
including TGF-β, IL-33, IL-12, IFN-I and TNF – can act individually or cooperatively to 
impair KLF2 expression20,95,130. Hence the specific cytokine milieu surrounding an 
activated CD4 T cell may dictate its KLF2 expression pattern. It is also worth noting that 
ICOS signaling, which is critical for Tfh differentiation, is mediated at least in part 
through PI3K81,131 and hence signals induced by ICOS-ICOSL interactions may inhibit 
KLF2 expression. 
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